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ABSTRACT 20 
Accumulation of unfolded proteins in the endoplasmic reticulum (ER) causes ER stress 21 
and activates a signalling network known as the unfolded protein response (UPR). Here 22 
we characterise how ER stress and the UPR inhibit insulin signalling. We find that ER 23 
stress inhibits insulin signalling by depleting the cell surface population of the insulin 24 
receptor. ER stress inhibits proteolytic maturation of insulin proreceptors by interfering 25 
with transport of newly synthesised insulin proreceptors from the ER to the plasma 26 
membrane. Activation of AKT, a major target of the insulin signalling pathway, by a 27 
cytosolic, membrane-bound chimera between the AP20187-inducible FV2E dimerisation 28 
domain and the cytosolic protein tyrosine kinase domain of the insulin receptor was not 29 
affected by ER stress. Hence, signalling events in the UPR, such as activation of the JNK 30 
MAP kinases or the pseudokinase TRB3 by the ER stress sensors IRE1α and PERK, do 31 
not contribute to inhibition of signal transduction in the insulin signalling pathway. 32 
Indeed, pharmacologic inhibition and genetic ablation of JNKs, as well as silencing of 33 
expression of TRB3, did not restore insulin sensitivity or rescue processing of newly 34 
synthesised insulin receptors in ER-stressed cells. 35 
HIGHLIGHT SUMMARY 36 
ER stress inhibits activation of AKT by insulin by depleting insulin receptors and interferes 37 
with delivery of newly synthesised insulin receptors to the cell surface. Bypass of the 38 
secretory pathway in synthesis of the cytosolic protein tyrosine kinase domain of the insulin 39 
receptor negates the effects of ER stress on activation of AKT by insulin. 40 
INTRODUCTION 41 
In mammalian cells, most secreted proteins and proteins residing in the plasma membrane or 42 
the secretory pathway are transported into the ER while their polypeptide chains are being 43 
assembled by translating ribosomes (Walter and Lingappa, 1986). In the ER, newly 44 
synthesised proteins fold into their native three-dimensional structures, undergo multiple post-45 
translational modifications including asparagine (N)-linked glycosylation (Hubbard and Ivatt, 46 
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1981; Kornfeld and Kornfeld, 1985) and the formation of disulphide bonds (Fewell et al., 47 
2001). Interaction of newly synthesised proteins with several chaperone systems facilitates 48 
their productive folding, but also serves as a quality control mechanism to retain newly 49 
synthesised proteins in the ER until they have completed their folding and maturation 50 
processes (Hebert and Molinari, 2007). Consequently, unfolded or only partially folded 51 
proteins are prevented from exiting the ER until they have completed their folding process or 52 
are targeted to degradation mechanisms if they fail to fold productively, such ER-associated 53 
degradation (ERAD) (Meusser et al., 2005) or ER-phagy (Bernales et al., 2006). 54 
The accumulation of unfolded and partially folded proteins in the ER activates a 55 
signalling network termed the unfolded protein response (UPR) (Schröder and Kaufman, 56 
2005; Walter and Ron, 2011). Three ER transmembrane proteins, the membrane-bound 57 
transcription factor ATF6 (Yoshida et al., 2000, 2001b), the protein kinase PERK (Shi et al., 58 
1998; Harding et al., 1999; Shi et al., 1999), and the protein kinase-endoribonuclease (RNase) 59 
IRE1α (Tirasophon et al., 1998) initiate signalling in the UPR. After cleavage from the 60 
endomembrane system ATF6 translocates to the nucleus and activates transcription of genes 61 
encoding ER-resident molecular chaperones and components of the ER-associated protein 62 
degradation machinery (Ye et al., 2000; Wu et al., 2007; Yamamoto et al., 2007). PERK 63 
transiently attenuates general translation in ER-stressed cells by phosphorylating the α subunit 64 
of eIF2 (Shi et al., 1998; Harding et al., 1999). Phosphorylation of eIF2α also promotes 65 
translation of mRNAs with several short upstream open reading frames leading to induction 66 
of the transcription factor CHOP (Harding et al., 2000) and the pseudokinase TRB3 (Ohoka et 67 
al., 2005). 68 
IRE1α is a bifunctional protein kinase-RNase (Tirasophon et al., 1998; Tirasophon et al., 69 
2000). The IRE1α RNase activity initiates splicing of XBP1 mRNA which encodes a bZIP 70 
transcription factor (Shen et al., 2001; Yoshida et al., 2001a; Calfon et al., 2002; Lee et al., 71 
2002). Spliced XBP1 (XBP1s) is a more potent transcriptional activator than unspliced XBP1 72 
(XBP1u) for genes encoding ER resident molecular chaperones, phospholipid biosynthetic 73 
enzymes, and proteins involved in ER-associated protein degradation (Shen et al., 2001; 74 
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Yoshida et al., 2001a; Calfon et al., 2002; Lee et al., 2002). In addition, relaxed specificity of 75 
the RNase activity mediates decay of many mRNAs encoding proteins targeted to the 76 
secretory pathway (Hollien and Weissman, 2006; Hollien et al., 2009; Gaddam et al., 2013). 77 
Through association with the E3 ubiquitin ligase TRAF2 IRE1α activates the JNK family of 78 
mitogen-activated protein kinases (Urano et al., 2000). 79 
Insulin signaling is initiated by binding of insulin to the insulin receptor, activation of the 80 
protein tyrosine kinase domain and tyrosine autophosphorylation of the insulin receptor, and 81 
extensive tyrosine phosphorylation of insulin receptor substrate (IRS) proteins [reviewed in 82 
(Saltiel and Kahn, 2001)], including phosphorylation of Y612, Y632, Y896, Y941, Y1173, 83 
and Y1229 in human IRS1 (Shoelson et al., 1992; Sun et al., 1993; Rocchi et al., 1995; Xu et 84 
al., 1995; Esposito et al., 2001; Hers et al., 2002). Phosphorylated Y612, Y632, and Y941 are 85 
binding sites for the Src homology 2 (SH2) domain of the p85α subunit of 86 
phosphatidylinositol (PI) 3-kinase (PI3K) (Sun et al., 1993; Rocchi et al., 1995; Esposito et 87 
al., 2001). After formation of PI-3,4-bis- and PI-3,4,5-trisphosphate by PI3K, 88 
phosphoinositide-dependent kinases (PDKs) and isoforms of the protein serine/threonine 89 
kinase AKT are recruited to the plasma membrane. Colocalization of PDKs and AKT to the 90 
plasma membrane facilitates phosphorylation of AKT on T308 by PDK1 (Alessi et al., 1996), 91 
and on S473 by mTORC2 (Sarbassov et al., 2005; Guertin et al., 2006; Jacinto et al., 2006), 92 
PAK1 (Mao et al., 2008), and ILK (McDonald et al., 2008) leading to activation of AKT. 93 
Activated AKT facilitates glucose transport, protein and glycogen synthesis, and inhibits 94 
gluconeogenesis. Recruitment of GRB2 to IRS1 phosphorylated at Y896 via its SH2 domain 95 
(Sun et al., 1993; Myers et al., 1994) activates mitogen-activated protein kinases, such as 96 
p42/p44, and contributes to generating a mitogenic signal in insulin-stimulated cells 97 
(Valverde et al., 2001). 98 
Inhibition of signal transduction in the insulin signalling pathway is the cause for insulin 99 
resistance when cells fail to respond normally to insulin. Insulin resistance can be caused by a 100 
decrease in insulin receptors or defects in signal transduction downstream of the insulin 101 
receptor. Activation of JNKs and TRB3 by the UPR has been implicated in the inhibition of 102 
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insulin signalling downstream of the insulin receptor (Özcan et al., 2004; Koh et al., 2006; 103 
Koh et al., 2013). JNKs inhibit tyrosine phosphorylation of IRS1 by the insulin receptor by 104 
phosphorylating S307 in murine IRS1 and S312 in human IRS1 (Aguirre et al., 2000; Aguirre 105 
et al., 2002). Consequently, phosphorylation and activation of AKT by insulin is inhibited by 106 
JNKs (Lee et al., 2003; Nguyen et al., 2005; Emanuelli et al., 2008). TRB3 interacts with and 107 
inhibits phosphorylation of AKT (Du et al., 2003) and also interacts with IRS1 and inhibits its 108 
phosphorylation at Y612 by the insulin receptor (Koh et al., 2013). 109 
JNKs become rapidly and transiently activated in ER-stressed cells to promote an 110 
adaptive response to ER stress (Brown et al., 2016). The motivation for this study was to 111 
characterise whether this rapid, initial JNK activation in the first 10 - 120 min of the ER stress 112 
response causes insulin resistance. However, we find no evidence for inhibition of insulin-113 
stimulated AKT phosphorylation or IRS1 tyrosine phosphorylation in cells exposed to ER 114 
stress for up to ~8-12 h despite activation of JNKs and induction of TRB3. Only ER stress 115 
lasting for more than ~8-12 h inhibited insulin-stimulated AKT phosphorylation, but did so 116 
independent of JNKs and TRB3, and correlated with depletion of β chains of the mature 117 
insulin receptor, accumulation of unprocessed α-β precursors of the insulin receptor in the 118 
ER, and depletion of GFP-tagged insulin receptors from the plasma membrane. Moreover, 119 
phosphorylation of AKT at S473 in response to activation of a cytosolic, membrane-bound 120 
chimera between the AP20187-inducible FV2E dimerisation domain (Clackson et al., 1998; 121 
Yang et al., 2000) and the protein tyrosine kinase domain of the insulin receptor is not 122 
affected by ER stress lasting for 24 h. We propose that inhibition of trafficking of newly 123 
synthesised insulin receptors to the plasma membrane suffices and is necessary to inhibit 124 
activation of AKT by insulin in ER-stressed cells by depleting the plasma membrane 125 
population of the insulin receptor. 126 
RESULTS 127 
ER stress for up to 8 h does not inhibit insulin-stimulated AKT activation. We used in vitro 128 
differentiated C2C12 myotubes, 3T3-F442A preadipocytes, and Hep G2 hepatoma cells to 129 
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characterise the effects of ER stress on insulin signalling, because these cell types are cell 130 
culture models of the main tissues and organs contributing to glucose homeostasis, muscle, 131 
adipose tissue, and the liver (Saltiel and Kahn, 2001). We first characterised whether ER 132 
stress induced with different ER stressors for up to 8 h inhibits signal transduction 133 
downstream of the insulin receptor by monitoring insulin-stimulated phosphorylation of AKT 134 
at T308 and S473 in in vitro differentiated C2C12 myotubes. C2C12 myotubes were serum-135 
starved for 18 h, treated with ER stressors for the last 1 to 8 h of serum starvation and then 136 
stimulated with 100 nM insulin for 15 min in the continued presence of ER stressors. 100 nM 137 
insulin was chosen, because inhibition of insulin signalling downstream of the receptor 138 
manifests independent of insulin concentration (Olefsky and Kolterman, 1981). To exclude 139 
drug specific effects on insulin signalling, we used three different ER stressors, the SERCA 140 
pump inhibitor thapsigargin (Thastrup et al., 1990), the N-glycosylation inhibitor tunicamycin 141 
(Kuo and Lampen, 1976; Lehle and Tanner, 1976), and the protease SubAB, which cleaves 142 
and inactivates the ER resident HSP70 class molecular chaperone BiP/GRP78 (Paton et al., 143 
2006). We also titrated the concentrations of both thapsigargin and tunicamycin in the culture 144 
medium over a 10- or 100-fold concentration range, respectively. AKT phosphorylation was 145 
chosen as readout, because its dynamic range is larger than the dynamic ranges of many 146 
physiological responses to insulin such as translocation of GLUT4 to the plasma membrane 147 
(Hoehn et al., 2008), uptake of 2-deoxyglucose (Whitehead et al., 2001), or glucose oxidation 148 
(Kono and Barham, 1971). Induction of ER stress with 0.1-1.0 μM thapsigargin, 0.1-10 μg/ml 149 
tunicamycin, or SubAB for up to ~8 h in C2C12 myotubes, however, did not decrease insulin-150 
stimulated phosphorylation of AKT at T308 (Figure 1, A and B) or S473 (Figure 1, A and C). 151 
To confirm that treatment of serum-starved C2C12 cells with ER stressors induces ER 152 
stress, we monitored XBP1 splicing using reverse transcriptase PCR. The IRE1α-initiated 153 
XBP1 splicing reaction removes a 26 nt intron from XBP1 mRNA. Therefore, the appearance 154 
of a shorter reverse transcriptase PCR product on 2% (w/v) agarose gels indicates activation 155 
of the RNase activity of IRE1α. Upon exposure of serum-starved C2C12 cells to 0.3 μM 156 
thapsigargin, 1 μg/ml tunicamycin, or 1 μg/ml SubAB a shorter reverse transcriptase PCR 157 
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product appeared (Figure 1, D), which represents spliced XBP1 mRNA. Strong induction of 158 
TRB3 mRNA after induction of ER stress for 4 or 8 h was also detected (Figure 1, E and F), 159 
which suggests that serum-starved C2C12 cells experience ER stress when challenged with 160 
thapsigargin, tunicamycin or SubAB. Furthermore, serum starvation did not decrease XBP1 161 
splicing in cells exposed to 1 μM thapsigargin for 1 h (Figure S1, A), which argues against 162 
the possibility that induction of ER stress is blunted by decreased protein synthesis rates in 163 
serum-starved cells. Thapsigargin-, tunicamycin-, or SubAB-induced ER stress for up to 12 h 164 
also did not inhibit insulin-stimulated AKT activation in 3T3-F442A adipocytes or Hep G2 165 
hepatoma cells, or over a period of 4 h in Fao rat hepatoma cells cultured in RPMI 1640 or 166 
Coon’s modification of Ham’s F12 medium (data not shown). 167 
JNKs are activated as early as 10 min after induction of ER stress in C2C12 myotubes and 168 
3T3-F442A adipocytes, and after 30 min in Hep G2 cells (Brown et al., 2016), which raises 169 
the possibility that ER stress may inhibit the insulin signalling pathway around these times in 170 
the ER stress response. However, 30 min of thapsigargin-induced ER stress did not decrease 171 
insulin-stimulated phosphorylation of AKT on S473 in 3T3-F442A adipocytes, C2C12 172 
myotubes, or Hep G2 cells (Figure S1, B and C). Induction of ER stress for 30 min with 173 
tunicamycin or SubAB also did not decrease insulin-induced phosphorylation of AKT (Figure 174 
S1, B and C). These results suggest that activation of JNKs by ER stress does not inhibit 175 
signal transduction in the insulin signalling pathway. To characterise whether lower, more 176 
physiologic insulin concentrations (Cryer and Polonsky, 1998; Unger and Foster, 1998) 177 
unmask effects of ER stress on insulin-stimulated AKT phosphorylation, we stimulated cells 178 
with 10 nM insulin for 15 min. ER stress induced with 0.3 μM thapsigargin, 1 μg/ml 179 
tunicamycin or SubAB for 30 min up to 8 h had no effect on phosphorylation of AKT on 180 
S473 in 3T3-F442A, C2C12, or Hep G2 cells stimulated with 10 nM insulin for 15 min (Figure 181 
2). In summary, these data establish that short periods of ER stress lasting for up to ~8 h, in 182 
which JNKs are activated (Brown et al., 2016) and TRB3 is induced (Figure 1, E and F), do 183 
not inhibit insulin-dependent AKT phosphorylation in 3T3-F442A, C2C12, Fao, and Hep G2 184 
cells. 185 
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ER stress for up to 30 min does not inhibit IRS1 tyrosine phosphorylation. Phosphorylation of 186 
AKT is downstream of tyrosine phosphorylation of IRS1 by the activated insulin receptor in 187 
the insulin signalling pathway (Backer et al., 1992; Franke et al., 1995). The absence of 188 
effects of heterozygosity for IRS1 in lean mice on control of blood glucose levels (Shirakami 189 
et al., 2002) and the lack of effects of partial shRNA-mediated knockdown of IRS1 in skeletal 190 
muscle on local glucose clearance (Cleasby et al., 2007) suggest that IRS1 is available in 191 
excess over the amounts needed for full activation of downstream events in the insulin 192 
signalling pathway. To address the possibility that decreases in IRS1 tyrosine phosphorylation 193 
in ER-stressed cells are not reflected at the level of AKT phosphorylation, we directly 194 
examined the effects of ER stress on IRS1 tyrosine phosphorylation. First, we characterised 195 
whether within the initial 30 min time window after induction of ER stress, in which ER 196 
stress activates JNKs in 3T3-F442A, C2C12, and Hep G2 cells (Brown et al., 2016), a decrease 197 
in tyrosine phosphorylation of specific, well-characterised insulin-responsive tyrosine 198 
phosphorylation sites, such as Y608 (mouse)/Y612 (human; from here on abbreviated as 199 
Y608/612), Y628/632, Y891/896, and Y935/941 (Shoelson et al., 1992; Sun et al., 1993; Xu 200 
et al., 1995; Hers et al., 2002), could be observed. We could extract intact IRS1 from 3T3-201 
F442A, C2C12, and Hep G2 cells only under strongly denaturing conditions such as 8 M urea, 202 
2.5% (w/v) SDS, or 7 M urea, 2 M thiourea, 2.5% (w/v) SDS, or 8 M guanidinium 203 
hydrochloride, 1% (v/v) Triton X-100, or 4 M guanidinium thiocyanate, 1% (v/v) Triton X-204 
100, or 10-20% (w/v) trichloroacetic acid (TCA, data not shown). In addition, detection of 205 
full-length IRS1 by Western blotting required electrotransfer onto PVDF membranes at pH 206 
~10 in the presence of SDS as described in “Materials and Methods”. Under these conditions, 207 
Western blots displaying one band at ~180 kDa, the migration position of IRS1 in SDS-208 
PAGE (Sun et al., 1991), were obtained with all four single tyrosine phosphorylation site 209 
antibodies and anti-IRS1 antibodies (Figures 3, S2, and S3). Antibodies against 210 
phosphorylated tyrosine phosphorylation sites gave much stronger signals on samples isolated 211 
from insulin-treated cells at ~180 kDa (Figures 3, S2, and S3). Induction of ER stress with 1 212 
μM thapsigargin for up to 30 min or with 0.1 μg/ml, 1 μg/ml, or 10 μg/ml tunicamycin for 30 213 
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min did not affect phosphorylation of Y608/612, Y628/632, Y891/896, or Y935/941 when 214 
cells were stimulated with 10 or 100 nM insulin for 5 min (Figures 3, S2, and S3). An ~3-fold 215 
increase in IRS1 levels upon insulin stimulation in 3T3-F442A cells (Figure S2) and an ~2-216 
fold increase in C2C12 myotubes and Hep G2 cells (Figures 3 and S3) were also not affected 217 
by thapsigargin or tunicamycin. 218 
Human IRS1 has 32 tyrosyl residues, while murine IRS1 has 34. Phosphorylation of at 219 
least 19 tyrosines in human IRS1 and 13 tyrosines in murine IRS1 has been shown 220 
experimentally (Hornbeck et al., 2015). An additional eight tyrosines in human IRS1 and nine 221 
tyrosines in murine IRS1 feature at least one acidic amino acid in the six immediately 222 
upstream amino acids. Upstream acidic amino acids can be a feature of tyrosine 223 
phosphorylation sites (Neil et al., 1981; Smart et al., 1981; Baldwin et al., 1982; Hunter, 224 
1982; Patschinsky et al., 1982; Pike et al., 1982; Baldwin et al., 1983) and are, for example, 225 
enriched in the experimentally confirmed tyrosine phosphorylation sites of human and murine 226 
IRS1 (human IRS1, upstream positions -1 to -3, χ2 p value < 0.05; murine IRS1, upstream 227 
positions -1 to -6, χ2 p value < 0.01). Given the large number of confirmed and putative 228 
tyrosine phosphorylation sites in IRS1, it is possible that individually surveying a subset of 229 
tyrosine phosphorylation sites may not uncover effects of ER stress on tyrosine 230 
phosphorylation of IRS1. To address this concern, we immunoprecipitated IRS1 from cell 231 
lysates prepared from unstressed cells, or cells that were exposed to 1 μM thapsigargin or 10 232 
μg/ml tunicamycin for 30 min and then stimulated with 10 or 100 nM insulin for 5 min in the 233 
continued presence of thapsigargin or tunicamycin, and Western blotted the 234 
immunoprecipitates with a pan-phosphotyrosine antibody (clone 4G10® Platinum), and an 235 
anti-IRS1 antibody (Figure 4). We observed a strong increase in tyrosine phosphorylation 236 
after stimulation with either 10 or 100 nM insulin for 5 min, but neither thapsigargin nor 237 
tunicamycin had any effect on the level of tyrosine phosphorylation of IRS1 (Figure 4). In 238 
summary, these data show that ER stress lasting for up to 30 min does not affect insulin-239 
stimulated IRS1 tyrosine phosphorylation. 240 
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ER stress does not elicit serine 307/312 phosphorylation of IRS1. JNKs inhibit tyrosine 241 
phosphorylation of IRS1 by the activated insulin receptor by phosphorylating IRS1 at 242 
S307/312 (Aguirre et al., 2000; Aguirre et al., 2002). Unaltered tyrosine phosphorylation of 243 
IRS1 in ER-stressed cells (Figures 3, 4, S2, and S3) suggested that JNKs, despite being 244 
activated by ER stress (Brown et al., 2016), do not phosphorylate IRS1 at S307/312 or that 245 
phosphorylation of IRS1 at S307/312 by JNKs does not inhibit tyrosine phosphorylation of 246 
IRS1 by the insulin receptor in ER-stressed cells. To distinguish between these possibilities, 247 
we measured IRS1 S307/312 phosphorylation in serum-starved cells and standardised the 248 
phospho-S307/S312 IRS1 signal to the signal for total IRS1 (Figure 5). We included 249 
treatment with 5 μg/ml anisomycin for 30 – 60 min, which has been reported to elicit 250 
phosphorylation of IRS1 at S307/312 (Aguirre et al., 2000; Aguirre et al., 2002; Werner et al., 251 
2004), as a positive control, because we obtained only faint signals with the anti-pS307/S312 252 
antibody with cell lysates prepared from cells exposed to 1 μM thapsigargin for up to 2 h 253 
(Figure 5). In 3T3-F442A and Hep G2 cells, anisomycin retarded migration of IRS1 in 7.5% 254 
SDS-PAGE gels (Figure 5, A and E). This suggests that IRS1 becomes phosphorylated at 255 
additional sites than those reported in the literature in response to anisomycin, S302/307 256 
(Werner et al., 2004), S307/312 (Aguirre et al., 2000; Aguirre et al., 2002; Werner et al., 257 
2004), and possibly S632/636 and S635/639 (Hiratani et al., 2005), to explain the shift in 258 
migration position. Retardation of IRS1 in SDS-PAGE was not seen in thapsigargin-treated 259 
cells (Figure 5). These data argue that ER stress induced with thapsigargin does not elicit 260 
S307/312 phosphorylation of IRS1 and that phosphorylation of IRS1 at other sites remains 261 
below the threshold necessary to affect retardation of IRS1 in SDS-PAGE. 262 
ER stress for ≥ 12 h inhibits insulin-stimulated AKT phosphorylation. Several studies have 263 
reported that ER stress lasting for 12 h or longer causes insulin resistance (Zhou et al., 2009; 264 
Avery et al., 2010; Xu et al., 2010; Tang et al., 2011; Hassan et al., 2012; Jung et al., 2013; 265 
Panzhinskiy et al., 2013). Such long periods of ER stress may cause insulin resistance by 266 
depleting the plasma membrane population of the insulin receptor, because the insulin 267 
receptor has a half-life of 7-13 h (Reed and Lane, 1980; Kasuga et al., 1981; Reed et al., 268 
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1981a; Reed et al., 1981b; Capeau et al., 1985; Savoie et al., 1986; Grako et al., 1992). For 269 
this reason, we characterised whether ER stress for ≥ 12 h decreases insulin-stimulated 270 
phosphorylation of AKT. 12 h after induction of ER stress, insulin-stimulated S473 271 
phosphorylation of AKT was decreased in C2C12 cells exposed to 10 μg/ml of tunicamycin 272 
(Figure 6, A and B). 18 h after induction of ER stress, several ER stressors and markedly 273 
lower tunicamycin concentrations decreased insulin-stimulated AKT phosphorylation at S473 274 
(Figure 6, A and B). After 24 h of ER stress, all ER stress-inducing conditions decreased 275 
insulin-stimulated AKT phosphorylation at S473 in C2C12 cells. 24 h of ER stress induced 276 
with thapsigargin, tunicamycin, or SubAB decreased cell numbers (Figure S4, A and B), but 277 
did not affect the activity of mitochondrial redox chains in the remaining cells (Figure S4, C), 278 
suggesting that remaining cells were viable and that loss of viability cannot explain the 279 
decrease in S473 phosphorylation of AKT. We made similar observations in Hep G2 and 280 
3T3-F442A cells. In Hep G2 cells, induction of ER stress for 18 h did not affect insulin-281 
stimulated phosphorylation of AKT, except when cells were exposed to 10 μg/ml tunicamycin 282 
(Figure S5, A and B). After 24 h of ER stress a ten-fold lower tunicamycin concentration also 283 
reduced insulin-stimulated AKT phosphorylation, and after 36 h all ER stress inducing 284 
conditions decreased insulin-stimulated AKT phosphorylation (Figure S5, A and B). 36 h of 285 
ER stress decreased the number of Hep G2 cells remaining in culture dishes (Figure S4, D 286 
and E), but did not affect the viability of the cells remaining in culture dishes (Figure S4, F). 287 
In 3T3-F442A cells, insulin-stimulated S473 phosphorylation of AKT started to decline after 288 
12 h of ER stress and continued to decline over the next 12 h (data not shown). These data 289 
confirm that periods of ER stress that exceed the half-life of the insulin receptor decrease 290 
insulin-stimulated AKT phosphorylation. 291 
Decreased insulin-stimulated AKT phosphorylation correlates with depletion of the β chain of 292 
the mature insulin receptor in ER-stressed cells. The hypothesis, that ER stress for > 12 h 293 
decreases insulin-stimulated S473 phosphorylation of AKT by depleting the insulin receptor 294 
at the plasma membrane, predicts a decrease of mature β chains of the insulin receptor over 295 
the duration of ER stress. The insulin receptor is synthesised as a proreceptor of ~190 kDa or 296 
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~210 kDa due to alternative glycosylation (Hwang and Frost, 1999). Cleavage of the 297 
proreceptor into mature α and β chains of ~135 kDa and ~95 kDa in the trans-Golgi network 298 
by several proprotein convertases (Robertson et al., 1993; Bravo et al., 1994) yields the 299 
mature insulin receptor. Western blotting of cell lysates with an antibody against the β chain 300 
of the insulin receptor revealed bands representing the proreceptor at ~190 kDa and ~210 kDa 301 
and the β chain at ~95 kDa (Figures 6A and S5A). C2C12 cells stressed with 10 μg/ml 302 
tunicamycin displayed a decrease in insulin receptor β chains 12 h after induction of ER stress 303 
that is around the same time at which this condition decreases insulin-stimulated AKT S473 304 
phosphorylation. After 18 and 24 h of ER stress, lower concentrations of ER stress and other 305 
ER stressors such as thapsigargin or SubAB also decreased insulin receptor β chains (Figure 306 
6, A and B). The decrease in insulin receptor β chains correlated with the decrease in insulin-307 
stimulated AKT phosphorylation (Figure 6, C). Exposure of Hep G2 cells to 18 h of ER stress 308 
did not affect the abundance of β chains of the mature insulin receptor (Figure S5, A). By 309 
contrast, after 24 h or 36 h of ER stress a decline in β chain abundance coincided with 310 
decreased phosphorylation of AKT on S473 by insulin (Figure S5, A and B). The decrease in 311 
S473 phosphorylation of AKT correlated with the decrease in β chain abundance in ER-312 
stressed Hep G2 cells (Figure S5, C) and 36 h of ER stress significantly increased 313 
unprocessed α-β proreceptors in Hep G2 cells (Figure S5, D). We also observed a correlation 314 
between a decrease in insulin receptor β chains and decreased, insulin-stimulated AKT 315 
phosphorylation in 3T3-F442A cells (data not shown). Insulin by itself, however, did not 316 
affect the abundance of β chains of the insulin receptor in any cell line (Figures 6A-B and 317 
S5A-B, and data not shown). In summary, these data establish that in ER-stressed cells a 318 
decrease in insulin-stimulated AKT phosphorylation correlates with a decrease in mature 319 
insulin receptors. 320 
Next, we characterised whether the depletion of β chains in ER-stressed cells is sufficient 321 
to decrease insulin-stimulated AKT phosphorylation by silencing expression of the insulin 322 
receptor gene in C2C12 myoblasts by using three small interfering (si) RNAs and comparing 323 
insulin-stimulated AKT S473 phosphorylation to cells transfected with a siRNA against 324 
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eGFP. All three siRNAs decreased insulin receptor mRNA steady-state levels by 50-70% 325 
(Figure 6, D) and mature β chains to a similar extent (Figure 6, E). Concomitant with the 326 
decrease in insulin receptor levels, insulin-stimulated AKT S473 phosphorylation was 327 
decreased by 50-80% (Figure 6, E). These experiments suggest that an ~50% decrease in 328 
insulin receptor levels suffices to decrease insulin-stimulated AKT S473 phosphorylation to a 329 
similar degree. In summary, these data suggest that depletion of β chains of the mature insulin 330 
receptor suffices to decrease insulin-stimulated AKT phosphorylation in ER-stressed cells. 331 
Inhibition of protein synthesis and synthesis of α-β proreceptors cannot fully explain 332 
decreased insulin-stimulated S473 phosphorylation of AKT in ER stress lasting for 24 h. ER 333 
stress may decrease mature insulin receptors by decreasing transcription of the insulin 334 
receptor gene (Örd and Örd, 2003; Jang et al., 2010), degrading the insulin receptor mRNA 335 
via the RIDD activity of IRE1α (Hollien and Weissman, 2006; Hollien et al., 2009), inhibiting 336 
translation of the insulin receptor mRNA, by interfering with folding and maturation of newly 337 
synthesised insulin receptors in the ER and transport of newly synthesised insulin receptors to 338 
the plasma membrane, or increasing the turnover of insulin receptors at the cell surface. 339 
Therefore, we decided to determine which of these processes contribute to lower levels of 340 
mature insulin receptors in ER-stressed cells. 341 
Reverse transcriptase-quantitative PCR (qPCR) showed that steady-state levels of the 342 
insulin receptor mRNA increase ~6 fold in ER-stressed C2C12 cells (Figure 7, A), thus making 343 
it unlikely that transcriptional effects or RIDD activity of IRE1α can explain loss of insulin 344 
receptor β chains in ER-stressed cells. 345 
To explore whether a translational arrest can explain the loss of β chains, we labelled 346 
newly synthesised proteins for 30 min with a mix of [35S]-L-methionine and [35S]-L-cysteine 347 
and measured incorporation of [35S]-L-methionine/[35S]-L-cysteine into protein by 348 
scintillation counting of TCA precipitates (Figure 7, B-D) or after separating equal amounts 349 
of proteins on SDS-PAGE gels by storage phosphor imaging (Figure 7, E). Storage phosphor 350 
signals were normalised to the intensity of Coomassie Brilliant Blue R-250 staining of the 351 
gels to account for small variations in loading of SDS-PAGE gels. Overall, scintillation 352 
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counting of TCA precipitates and storage phosphor imaging of gels gave very similar results 353 
(Figure 7, B-E). In C2C12 and Hep G2 cells, 0.1 μM thapsigargin decreased protein synthesis 354 
rates measured by scintillation counting to 52 ± 4% and 66 ± 4% of untreated cells, 355 
respectively, or 55 ± 3% and 79 ± 2% when measured by storage phosphor imaging. In 356 
contrast, treatment with 0.1 μg/ml tunicamycin for 24 h did not affect protein synthesis rates 357 
(Figure 7, C-E). Surprisingly, both thapsigargin and tunicamycin increased protein synthesis 358 
rates in 3T3-F442A cells 1.97 ± 0.04 and 1.61 ± 0.03-fold when measured by storage 359 
phosphor imaging, and 2.1 ± 0.1 and 2.1 ± 0.2-fold when measured by scintillation counting. 360 
These effects of both thapsigargin and tunicamycin on protein synthesis rates in 3T3-F442A 361 
cells were seen in four independent experiments. To investigate if decreased protein synthesis 362 
in thapsigargin-treated C2C12 and Hep G2 cells may be caused by increased phosphorylation 363 
of eIF2α at S51, we examined phosphorylation of eIF2α at S51 by Western blotting. While 364 
treatment with 0.1 μM thapsigargin for 30 min led to a dramatic increase in phosphorylation 365 
of eIF2α in all three cell types, neither treatment with 0.1 μM thapsigargin or 0.1 μg/ml 366 
tunicamycin for 24 h affected phosphorylation of eIF2α at S51 (Figure 7, F). Therefore, the 367 
inhibitory effect of 24 h of thapsigargin treatment of C2C12 and Hep G2 cells on protein 368 
synthesis rates is independent of phosphorylation of eIF2α at S51. 369 
To directly establish whether ER stress affects synthesis of new insulin receptors, we 370 
measured synthesis rates of the α-β proreceptor by incorporation of [35S]-L-methionine/[35S]-371 
L-cysteine into newly synthesised proteins and immunoprecipitation of the insulin receptor 372 
with an antibody against the β chain of the mature insulin receptor. Immunoprecipitates were 373 
resolved by SDS-PAGE after boiling for 5 min in 10% (w/v) SDS and 2.5% (v/v) β-374 
mercaptoethanol (see ‘Materials and Methods’ for details). Initial experiments showed very 375 
faint bands for both the α-β proreceptor and β chain in cell lysates prepared from C2C12 cells 376 
labelled for 8 h with ~70% [35S]-L-methionine/~25% [35S]-L-cysteine (data not shown). Much 377 
stronger signals obtained with lysates prepared from Hep G2 and especially 3T3-F442A cells 378 
labelled for 8 h allowed us to identify several bands that were not observed in a control 379 
immunoprecipitation with normal rabbit IgG (Figure 7, G). The running positions of these 380 
 15 
bands in SDS-PAGE identified two of these bands as the α-β proreceptor and the β chain of 381 
the mature insulin receptor (Figure 7, G). When cells were labelled for 1 h with [35S]-L-382 
methionine/[35S]-L-cysteine, the band representing the β chain of the mature insulin receptor 383 
was no longer detected (Figure 7, G). Quantification of storage phosphor signals revealed that 384 
in 3T3-F442A cells ≤ 2.6 ± 0.4 % and in Hep G2 cells ≤ 9.0 ± 0.1% of α-β proreceptors were 385 
processed to mature insulin receptors in the 1 h label. These values likely represent an upper 386 
limit of α-β proreceptor processing in the 1 h label, because of the contribution of other 387 
comigrating, [35S]-L-methionine/[35S]-L-cysteine-labelled proteins to the storage phosphor 388 
signal at the migration position of the β chain. Hence, the amount of α-β proreceptors 389 
synthesised in the 1 h labelling period is representative of the synthesis rate of the α-β 390 
proreceptor. 391 
Consistent with total protein synthesis rates, 3T3-F442A cells treated for 24 h with 0.1 392 
μM thapsigargin showed a 2.33 ± 0.04-fold increase in α-β proreceptor synthesis, while 393 
treatment of 3T3-F442A cells with 0.1 μg/ml tunicamycin or Hep G2 cells with either 0.1 μM 394 
thapsigargin or 0.1 μg/ml tunicamycin for 24 h did not affect α-β proreceptor synthesis 395 
(Figure 7, G and H). When cells were treated with tunicamycin, α-β proreceptors migrated 396 
faster in SDS-PAGE due to their decreased molecular weights caused by inhibition of N-397 
glycosylation by tunicamycin (Figure 7, G). In summary, these experiments reveal that 398 
conditions exist in which ER stress for >12 h decreases insulin-stimulated S473 399 
phosphorylation of AKT without decreasing general protein synthesis or synthesis of the 400 
insulin proreceptor, for example exposure of C2C12 cells for 24 h to 0.1 μg/ml tunicamycin 401 
(Figures 6 and 7), and 24-36 h exposure of Hep G2 cells to low concentrations of thapsigargin 402 
or tunicamycin (Figures S5 and 7). 403 
ER stress does not increase the rate of insulin receptor turnover at the cell surface. Another 404 
possibility for how ER stress may deplete β chains of the mature insulin receptor is that 405 
increased proteolytic activity associated with the secretory pathway, either lysosomal 406 
proteolytic activity (Chiang et al., 2012; Imanikia et al., 2019) or proteasomal activity 407 
associated with the ER (Casagrande et al., 2000; Friedlander et al., 2000; Termine et al., 408 
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2009; Ron et al., 2011; Chiang et al., 2012), results in increased turnover of mature insulin 409 
receptors in ER-stressed cells. To address this possibility, we determined the half-life of the 410 
insulin receptor at the cell surface in unstressed cells, and cells in which ER stress was 411 
induced with 0.3 μM thapsigargin, 1 μg/ml tunicamycin, or 1 μg/ml SubAB. We biotinylated 412 
surface exposed proteins with the membrane-impermeable biotinylation reagent 413 
sulphosuccinimidyl-6-(biotinamido)hexanoate, and then continued to culture cells in the 414 
presence or absence of ER stressors for up to 72 h. At several times after biotinylation of cell 415 
surface proteins, we analysed proteins isolated with streptavidin-agarose beads by SDS-416 
PAGE and Western blotting. The stability of the streptavidin-biotin interaction in 6 M urea 417 
(Kurzban et al., 1991) allowed us to wash streptavidin-agarose beads twice with 6 M urea, 1% 418 
(v/v) Triton X-100 to remove non-biotinylated proteins. Western blotting of proteins isolated 419 
on streptavidin-agarose beads for the abundant intracellular protein GAPDH revealed that 420 
GAPDH was not retained on streptavidin agarose beads (Figure 8), showing that intracellular 421 
proteins were not biotinylated and that GAPDH was not retained on the beads via nonspecific 422 
interactions. Streptavidin-agarose beads also did not purify any insulin receptors from cells 423 
that were not exposed to the biotinylation reagent (Figure 8, A, C, and E, lanes labelled ‘-‘), 424 
showing that insulin receptors were only retained on streptavidin-agarose beads when they 425 
were biotinylated and, hence, surface exposed. When the supernate of a pull-down reaction 426 
with streptavidin-agarose beads was used in a second pull-down reaction with a new aliquot 427 
of streptavidin-agarose beads (Figure 8, A, C, and E, lanes labelled ‘0‘ and marked with an 428 
arrowhead), no or only faint bands were obtained for the β chain of the insulin receptor, 429 
showing that the yield of the first pull-down reaction consistently was > 96%. In all cell lines 430 
and under all conditions the abundance of insulin receptors that bound to streptavidin-agarose 431 
beads decreased over time, indicating that initially surface exposed and biotinylated insulin 432 
receptor molecules were degraded. In all cases the decay of biotinylated insulin receptors 433 
followed a monoexponential relationship (Figure 8). This allowed us to calculate half-lives 434 
for the insulin receptor at the cell surface from the slopes of linearised relationships and to 435 
compare half-lives between unstressed cells and cells exposed to ER stressors (Figure 8). The 436 
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calculated half-lives are similar to previously reported half-lives of total cellular insulin 437 
receptors (Reed and Lane, 1980; Kasuga et al., 1981; Krupp and Lane, 1981; Reed et al., 438 
1981a; Reed et al., 1981b; Grako et al., 1992) and insulin receptors at the cell surface (Rosen 439 
et al., 1979; Kasuga et al., 1981; Savoie et al., 1986). In C2C12 and Hep G2 cells, induction of 440 
ER stress with 0.3 μM thapsigargin, 1 μg/ml tunicamycin, or 1 μg/ml SubAB did not alter the 441 
half-life of the insulin receptor at the cell surface (Figure 8, D and F). By contrast, ER stress 442 
increased the half-life of insulin receptors at the surface of 3T3-F442A cells (Figure 8, B). 443 
Therefore, increased turnover and degradation of cell surface-exposed insulin receptors 444 
cannot explain the loss of insulin receptors leading to a decrease in insulin-stimulated S473 445 
phosphorylation of AKT in ER stressed cells. 446 
Unprocessed α-β proreceptors accumulate in the ER of ER-stressed cells. Since effects on 447 
transcription, translation, or degradation of insulin receptors cannot fully explain loss of 448 
mature insulin receptors in ER-stressed cells, we characterised whether transport of newly 449 
synthesised insulin receptors to the plasma membrane is inhibited by ER stress. Consistent 450 
with this hypothesis is that while mature β chains decrease in ER-stressed cells, the levels of 451 
α-β proreceptors increase relative to the levels of the β chains (Figures 9A and S5D). This 452 
suggests that α-β proreceptors accumulate in an early compartment of the secretory pathway 453 
such as the ER or cis-Golgi, because cleavage of the proreceptor into α- and β chains occurs 454 
in the trans-Golgi network (Robertson et al., 1993; Bravo et al., 1994). To provide additional 455 
evidence that proreceptors accumulate in the ER or cis-Golgi, we digested protein extracts 456 
from un- and ER-stressed C2C12 cells with Endo H. Endo H releases high mannose and some 457 
hybrid type N-linked oligosaccharides from glycoproteins by cleaving between the two N-458 
acetylglucosamine units (Maley et al., 1989). High mannose oligosaccharides are 459 
characteristic of proteins that have not been processed by enzymes in the Golgi complex. 460 
Endo H-digested α-β proreceptors migrated at the same position in SDS-PAGE as fully 461 
deglycosylated proreceptors synthesised in tunicamycin-treated cells (Figure 9, B and D) or 462 
obtained with PNGase F (Maley et al., 1989) (Figure 9, B-D), suggesting that none of the N-463 
glycans on the majority of α-β proreceptors were exposed to processing enzymes of the Golgi 464 
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complex. By contrast, mature α and β chains carry both Endo H sensitive and Endo H-465 
resistant N-linked oligosaccharides [(Heidenreich and Brandenburg, 1986; Hwang and Frost, 466 
1999) and Figure 9, D]. These data are consistent with the conclusion that α-β proreceptors 467 
accumulate in the ER or cis-Golgi of ER-stressed cells. 468 
To directly establish whether insulin receptors deplete at the plasma membrane and 469 
accumulate in intracellular compartments, we compared the localisation of C-terminally GFP-470 
tagged insulin receptors expressed in HEK 293 cells treated for 18 h with 0.1 μg/ml 471 
tunicamycin or 1 μg/ml SubAB to untreated HEK 293 cells. HEK 293 cells were chosen for 472 
these experiments because they can be easily transfected, in contrast to Hep G2 cells, do not 473 
grow in clumps, and adhered better to culture vessels when treated with ER stressors than 474 
C2C12 cells. ER stress lasting for 18 h depletes insulin receptor β chains in HEK 293 cells 475 
(Figure 9, E) and slightly decreases cell numbers (Figure 9, F). In unstressed cells, the GFP-476 
tagged insulin receptor predominantly localised to the plasma membrane (Figure 9, G), which 477 
is supported by the high Pearson’s correlation coefficient, robs, for the GFP fluorescence and 478 
the fluorescence of the CellMask Deep Red plasma membrane stain (Figure 9, H). By 479 
contrast, ER-stressed HEK 293 cells displayed intracellular GFP fluorescence and decreased 480 
colocalisation of GFP and CellMask Deep Red fluorescence (Figure 9, G and H). These 481 
observations are consistent with the conclusion that ER stress depletes the population of 482 
insulin receptors at the plasma membrane by interfering with trafficking of newly synthesised 483 
insulin receptors from the ER to the plasma membrane. 484 
AKT activation by a cytosolic FV2E-insulin receptor chimera is not affected by ER stress. To 485 
establish whether inhibition of transport of insulin receptors in the secretory pathway is 486 
necessary for ER stress to cause insulin resistance, we bypassed the secretory pathway in 487 
synthesis of functional insulin receptor protein tyrosine kinase domains by creating a chimera 488 
in which the signal peptide, extracellular and transmembrane domains of the insulin receptor 489 
have been replaced by an N-terminal myristoylation signal and the FV2E domain (Figure 10, 490 
A). The myristoylation signal mediates N-terminal myristoylation of the protein and its 491 
anchoring to intracellular membranes (Maurer-Stroh et al., 2002a, b). The FV2E domain 492 
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contains two binding sites for the bivalent macrolide AP20187 and binds AP20187 with 493 
subnanomolar affinities (Clackson et al., 1998; Yang et al., 2000). Binding of AP20187 to the 494 
FV2E domain induces dimerisation of the chimeric protein. Dimerisation of the FV2E-insulin 495 
receptor chimera with AP20187 in stably transfected Flp-In T-Rex 293 cells increased 496 
phosphorylation of the chimera at tyrosine 610, which is equivalent to tyrosine 1355 in the 497 
long isoform of the human insulin receptor, showing that the chimera possesses tyrosine 498 
autophosphorylation activity (Figure 10, B). Because AKT S473 phosphorylation was 499 
unresponsive to serum starvation in Flp-In T-Rex 293 cells (data not shown), we transiently 500 
transfected the chimera into C2C12 myoblasts. In C2C12 cells, AP20187 stimulated AKT S473 501 
phosphorylation ~4.5 fold (Figure 10, C and D). Thus, activation of the FV2E-insulin receptor 502 
chimera recapitulates several events in insulin signalling. In transiently transfected C2C12 cells 503 
ER stress induced for 24 h with thapsigargin, tunicamycin, or SubAB reduced endogenous β 504 
chains by ~40% (Figure 10, C) but did not affect activation of AKT by the chimera (Figure 505 
10, C and D). Furthermore, ER stress induced with thapsigargin, tunicamycin, or SubAB 506 
increased the abundance of unprocessed endogenous α-β proreceptors (Figure 10, E) and 507 
induced TRB3 (Figure 10, F). Hence, activation of AKT by the cytosolic, AP20187-508 
stimulated insulin receptor chimera is not affected by ER stress despite induction of TRB3, 509 
depletion of β chains of the mature, endogenous insulin receptor, and accumulation of 510 
unprocessed endogenous α-β proreceptors. 511 
Pharmacologic inhibition of JNKs does not rescue insulin-stimulated S473 phosphorylation 512 
of AKT in ER-stressed cells. Previous work has suggested that activation of both the family of 513 
JNK MAP kinases and TRB3 by ER stress leads to a decrease in insulin-stimulated AKT 514 
phosphorylation in ER-stressed cells (Özcan et al., 2004; Koh et al., 2006; Koh et al., 2013). 515 
The lack of effects of 24 h of ER stress on the FV2E-insulin receptor chimera (Figure 10) 516 
prompted us to characterise whether the decrease in insulin-stimulated AKT phosphorylation 517 
in cells experiencing ER stress for >12 h manifests independent of activation of JNKs or 518 
TRB3. We first characterised JNK activation in C2C12 and Hep G2 cells exposed to ER stress 519 
for 12 – 36 h using phosphorylation of JNKs at T183 and Y185 in their T-loops as a marker 520 
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for their activation (Lawler et al., 1998; Fleming et al., 2000). No signals for JNKs 521 
phosphorylated at T183 and Y185 were obtained for C2C12 cells exposed to 0.1 – 1.0 μM 522 
thapsigargin, 0.1 – 10 μg/ml tunicamycin, or 1 μg/ml SubAB for 12, 18, or 24 h or Hep G2 523 
cells exposed to 0.1 – 10 μg/ml tunicamycin or 1 μg/ml SubAB for 18, 24, or 36 h in Western 524 
blots, despite detecting very strong signals in cells irradiated with UV light (400 J/m2, λ = 254 525 
nm; Figure 11, A and data not shown). Thus, if JNKs are activated in these conditions, the 526 
levels of JNK species phosphorylated at T183 and Y185 are below levels that can be detected 527 
by Western blotting. By contrast, exposure of Hep G2 cells to 0.1 – 1.0 μM thapsigargin for 528 
18 – 36 h revealed activation of JNKs (Figure 11, A). Additional bands detected with the anti-529 
phospho-T183-phospho-Y185-JNK antibody that migrate below the migration position of the 530 
46 and 54 kDa isoforms of JNKs may represent phosphorylated species of other MAP 531 
kinases, such as p38, p42, and p44 (Figure 11, A), suggesting that exposure to thapsigargin 532 
for ≥18 h may activate several MAP kinases in Hep G2 cells. 533 
To evaluate whether the JNK activation brought about by thapsigargin in Hep G2 cells 534 
contributes to the loss of insulin-stimulated S473 phosphorylation of AKT, we employed two 535 
selective JNK inhibitors, N-(4-amino-5-cyano-6-ethoxypyridin-2-yl)-2-(2,5-536 
dimethoxyphenyl)acetamide (JNKi VIII) and (E)-3-(4-(dimethylamino)but-2-enamido)-N-(3-537 
methyl-4-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide (JNKi XVI). Both 538 
inhibitors inhibited phosphorylation of the JNK substrate c-Jun in Hep G2 cells stimulated 539 
with UV or 5 μg/ml anisomycin for 30 min with submicromolar EC50 values that are 540 
comparable to previously reported EC50 values for inhibition of c-Jun phosphorylation in 541 
TNF-α treated Hep G2 or HeLa cells (Szczepankiewicz et al., 2006; Zhang et al., 2012) 542 
(Figure S6). Both inhibitors also inhibited c-Jun phosphorylation at S63 in Hep G2 cells 543 
exposed to 0.1 – 1.0 μM thapsigargin for 36 h (Figure 11, B). Thapsigargin increased steady-544 
state levels of c-Jun (Figure 11, B), which is consistent with c-Jun autoregulating its own 545 
expression (Angel et al., 1988). 8 μM of JNKi XVI decreased the increase in c-Jun levels, 546 
while the same concentration of JNKi VIII had no effect on the increase in c-Jun levels in 547 
thapsigargin-treated Hep G2 cells (Figure 11, B), which correlates with the stronger inhibition 548 
 21 
of c-Jun S63 phosphorylation elicited by thapsigargin by JNKi XVI. Both JNK inhibitors, 549 
however, did not reverse inhibition of phosphorylation of S473 of AKT in Hep G2 cells that 550 
were exposed to 0.1 – 1.0 μM thapsigargin for 36 h, and then stimulated with 10 or 100 nM 551 
insulin for 15 min in the continued presence of thapsigargin (Figure 11, C-E). Both JNK 552 
inhibitors decreased the insulin-stimulated phosphorylation of AKT at S473 (Figure 11, C and 553 
D). Normalisation of S473 phosphorylation of AKT to the sample not exposed to thapsigargin 554 
within each group (no JNKi, treatment with JNKi VIII or XVI) reinforced the conclusion that 555 
both inhibitors do not reverse the inhibitory effect of thapsigargin on insulin-stimulated S473 556 
phosphorylation of AKT (Figure 11, E). Consistent with this observation and the proposed 557 
role for depletion of insulin receptors in ER-stressed cells as the cause for inhibition of 558 
insulin-stimulated S473 phosphorylation of AKT, both JNK inhibitors also did not rescue 559 
levels of β chains of the mature insulin receptor or α-β proreceptor processing in Hep G2 cells 560 
exposed to 0.1 – 1.0 μM thapsigargin for 36 h (Figure 11, F). 561 
Genetic ablation of JNK1 and JNK2 does not protect mouse embryonic fibroblasts (MEFs) 562 
from inhibition of insulin-stimulated AKT phosphorylation by ER stress. To confirm the 563 
results obtained with pharmacologic inhibitors of JNKs we compared the effects of 24 h of 564 
ER stress on insulin-stimulated S473 phosphorylation of AKT in wild type (WT) MEFs and 565 
MEFs deficient in the JNK1 and JNK2 isoforms of the JNK kinases. These jnk1-/- jnk2-/- 566 
MEFs lack detectable JNK activity because these cells do not express the neuronal isoform of 567 
the JNKs, JNK3 (Tournier et al., 2000). Exposure of WT and jnk1-/- jnk2-/- MEFs to 568 
thapsigargin, tunicamycin or SubAB for 24 h to elicit ER stress decreased insulin-stimulated 569 
AKT phosphorylation in both cell types to the same degree (Figure 12, A-C), despite a 6.1 ± 570 
0.6 increase in phosphorylation of JNKs in ER-stressed WT MEFs ((p < 0.0001 in an ordinary 571 
one-way ANOVA, Figure 12, D and E). ER stress also caused similar increases in the 572 
abundance of unprocessed α-β insulin proreceptors in WT and jnk1-/- jnk2-/- MEFs (Figure 12, 573 
F), which suggests that activation of the JNK kinases in the ER stress response does not affect 574 
the protein folding capacity of the stressed ER. 575 
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siRNA-mediated silencing of expression of TRB does not protect from inhibition of insulin-576 
stimulated AKT phosphorylation by ER stress. To characterise whether TRB3 contributes to 577 
the decrease in insulin-stimulated AKT phosphorylation in cells that experience ER stress for 578 
24 h, we used two siRNAs to knock-down expression of TRB3. 48 h after transfection of 579 
C2C12 myoblasts, both siRNAs decreased TRB3 mRNA and protein levels to a similar degree 580 
(Figure 13, A and B). However, the knock-down of TRB3 mRNA and protein levels did not 581 
affect insulin-stimulated phosphorylation of AKT (Figure 13, C and D) or the accumulation 582 
of unprocessed α-β insulin proreceptors (Figure 13, E) in cells exposed to thapsigargin, 583 
tunicamycin, or SubAB to elicit ER stress. These data argue that TRB3 does not contribute to 584 
decreased insulin-stimulated AKT phosphorylation or restoration of the protein folding 585 
capacity of cells that experience ER stress for 24 h. Taken together, the dispensability for 586 
JNKs and TRB3, as well as the absence of effects of ER stress on activation of AKT by the 587 
FV2E-insulin receptor chimera, argue that ER stress decreases insulin-stimulated AKT 588 
phosphorylation independent of signal transduction events. 589 
DISCUSSION 590 
The data presented here establish that ER stress interferes with insulin-stimulated 591 
phosphorylation of AKT by inhibiting the processing of newly synthesised insulin receptors 592 
in the secretory pathway, which will deplete the cell surface population of the receptor over 593 
time (Figure 14, A). Several lines of evidence support this conclusion. ER stress extending 594 
over several half-lives of the insulin receptor at the plasma membrane inhibits insulin-595 
stimulated AKT phosphorylation (Figures 6 and S5). Periods of ER stress shorter than the 596 
half-life of 6-12 h for the insulin receptor at the plasma membrane in ER-stressed cells 597 
(Figure 8) do not affect S473 phosphorylation of AKT by insulin (Figures 1, 2, and S1) or 598 
IRS1 tyrosine phosphorylation (Figures 3, 4, S2, and S3). The inhibition of insulin-stimulated 599 
AKT phosphorylation in ER-stressed cells coincides with a decrease in the abundance of 600 
mature insulin receptors (Figures 6A-C and S5A-C). Colocalisation experiments revealed that 601 
while GFP-tagged insulin receptors localise to the plasma membrane of unstressed cells, this 602 
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localisation of insulin receptors to the plasma membrane decreases in ER-stressed cells 603 
(Figures 9, G and H). At the same time GFP-tagged insulin receptors accumulate within the 604 
cell (Figure 9, G). Unprocessed α-β proreceptors, whose N-glycans remained sensitive to 605 
Endo H (Figure 9, B), accumulate in ER-stressed cells (Figures 9A and S5D), suggesting that 606 
unprocessed α-β proreceptors do not reach the trans-Golgi where they are processed to 607 
mature receptors (Robertson et al., 1993; Bravo et al., 1994). siRNA-mediated knock-down of 608 
expression of the insulin receptor confirmed that a ~50% decrease in insulin receptor levels 609 
suffices to cause a similar decrease in insulin-stimulated AKT phosphorylation (Figure 6, E). 610 
Finally, the absence of effects of ER stress on phosphorylation by the activated chimera of the 611 
FV2E domain and protein tyrosine kinase domain of the insulin receptor (Figure 10) showed 612 
that processing of insulin receptors in the secretory pathway is necessary for ER stress to 613 
inhibit insulin signalling. These experiments also suggested that signalling events in the UPR, 614 
such as activation of JNKs or TRB3, do not affect insulin signalling downstream of the 615 
insulin receptor. Pharmacologic inhibition and genetic ablation of JNKs (Figures 11 and 12) 616 
and siRNA-mediated silencing of TRB3 (Figure 13) confirmed these conclusions. 617 
In previous research tunicamycin was nearly exclusively used to inhibit trafficking of 618 
newly synthesised insulin receptors (Keefer and De Meyts, 1981; Reed et al., 1981b; Ronnett 619 
and Lane, 1981; Boyd and Raizada, 1983; Ercolani et al., 1984; Kadle et al., 1984; Ronnett et 620 
al., 1984; Capeau et al., 1985; Goldstein and Kahn, 1988), which led to the conclusion that 621 
the underlying cause for the trafficking defect is the lack of N-glycosylation of newly 622 
synthesised insulin receptors. We show that two other ER stressors, thapsigargin and SubAB, 623 
also inhibit processing of α-β proreceptors to mature receptors (Figures 9A and S5A) 624 
suggesting that newly synthesised α-β proreceptors do not reach the trans-Golgi to be cleaved 625 
into mature α- and β-chains. This conclusion is supported by the observation that all N-626 
glycans of α-β proreceptors in cells treated with thapsigargin or SubAB remain sensitive to 627 
Endo H (Figure 9, B). The migration of α-β proreceptors synthesised in the presence of 628 
thapsigargin or SubAB in SDS-PAGE suggests that these proreceptors are N-glycosylated to 629 
the same extent as proreceptors synthesised by unstressed cells (Figures 6A, 7G, 9B, and 630 
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S5A), suggesting that both thapsigargin and SubAB do not inhibit N-glycosylation of newly 631 
synthesised insulin receptors. Therefore, events other than lack of N-glycosylation can inhibit 632 
transport of newly synthesised insulin receptors from the ER to the trans Golgi. Cleavage and 633 
inactivation of the ER luminal HSP70 chaperone BiP by SubAB (Paton et al., 2006) may 634 
interfere with correct folding of newly synthesised insulin receptors, leading to their retention 635 
in the ER by the quality control machinery of the ER (Bass et al., 1998) and, to some extent, 636 
targeting of unfolded proreceptors to ERAD machinery for degradation. The effects of 637 
thapsigargin on protein folding in the ER are less well understood, but depletion of the ER 638 
luminal Ca2+ store by thapsigargin (Thastrup et al., 1990) may inhibit several molecular 639 
chaperones of the ER, because many of these bind Ca2+ ions with high capacities (Macer and 640 
Koch, 1988; Fliegel et al., 1989; Wada et al., 1991). Indirect effects resulting from depletion 641 
of proteins functioning in vesicular trafficking and sorting may also account for some of the 642 
effects on insulin receptor trafficking, and may, for example, explain the increased half-life of 643 
the insulin receptor at the plasma membrane in ER-stressed 3T3-F442A cells (Figure 8, A-B). 644 
Insulin resistance can be a consequence of decreased insulin receptor levels, inhibition of 645 
transduction of the insulin signal downstream of the insulin receptor (sometimes referred to as 646 
‘post-receptor events’), or a combination of the two (Olefsky and Kolterman, 1981). The 647 
experiments with the FV2E-insulin receptor chimera (Figure 10) show that ER stress does not 648 
affect insulin signalling downstream of the receptor. Our work also establishes that plasma 649 
membrane levels of the receptor decrease (Figures 9, G and H). Therefore, we propose that 650 
ER stress primarily causes insulin resistance by decreasing the levels of insulin receptors at 651 
the cell surface. Decreases in insulin receptors affect insulin sensitivity of cells, in other 652 
words, shift the response curve to insulin towards higher insulin concentrations, but only 653 
decrease the response to insulin when receptors become severely depleted (see, for example, 654 
Figure 14, B and C, curves labelled ‘0’ and ‘1’ in B) (Olefsky and Kolterman, 1981). 655 
Elevated insulin concentrations can compensate for decreased insulin sensitivity, because 656 
many cell types possess ‘spare’ receptors, which allows them to mount maximal responses to 657 
insulin even when only a small fraction of receptors have bound to insulin, possibly as low as 658 
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a few percent (Kono and Barham, 1971; Olefsky, 1975; Le Marchand-Brustel et al., 1978; 659 
Hofmann et al., 1980; Frank et al., 1981). A decrease in insulin receptors will diminish the 660 
response to insulin at one insulin concentration, but because insulin, the insulin receptor, and 661 
insulin-insulin receptor complexes are in a dynamic equilibrium, increases in the insulin 662 
concentration will compensate for the decrease in insulin receptor concentration, and allow 663 
for formation of a sufficient number of insulin-insulin receptor complexes to elicit a maximal 664 
response to insulin. By contrast, a decrease in the response to insulin at all insulin 665 
concentrations is often indicative of inhibition of signal transduction downstream of the 666 
insulin receptor (Olefsky and Kolterman, 1981). Hence, when high insulin concentrations are 667 
employed, as is often done in in vitro studies, this is expected to primarily reveal post-668 
receptor events on insulin signalling because these affect insulin signalling independent of 669 
insulin concentration, and the high insulin concentration is thought to compensate for 670 
decreases in insulin sensitivity. 671 
This, however, changes when insulin receptor levels decrease to such an extent that the 672 
concentration of insulin-insulin receptor complexes approaches the value of KE, the 673 
concentration of the hormone, or more precisely hormone-receptor complexes, at which the 674 
response to the hormone is half-maximal. At this point, the response to insulin will decrease 675 
over the whole insulin concentration range (Figure 14, B and C), and complete compensation 676 
by increasing insulin concentrations may, depending on the magnitude of the decrease in 677 
insulin receptor levels, no longer be possible. It then also becomes difficult, if not impossible, 678 
to distinguish between an effect on insulin sensitivity (due to decreased receptor levels) and 679 
post-receptor events, even if dose-response curves are recorded or high insulin concentrations 680 
are employed. Therefore, while previous studies have largely interpreted effects of ER stress 681 
for > 12 h as post-receptor events (Avery et al., 2010; Xu et al., 2010; Tang et al., 2011; 682 
Hassan et al., 2012; Jung et al., 2013; Panzhinskiy et al., 2013), it is also possible that the 683 
effects of long periods of ER stress are, at least in part, the consequence of profound 684 
decreases in insulin receptors and subsequently insulin sensitivity. The FV2E-insulin receptor 685 
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chimera described in this work may prove to be a valuable tool to distinguish more rigorously 686 
between receptor and post-receptor events in future work. 687 
The interpretation of effects of ER stress on insulin signalling is further complicated by 688 
the gradual decrease of insulin receptors at the plasma membrane over time until receptor 689 
levels fall below the critical level, at which cells do no longer retain their complete 690 
responsiveness to insulin. The time it takes for insulin receptor levels to fall to this critical 691 
level depends on (a) the half-life of the receptor at the cell surface, which is affected by cell 692 
type and can be affected by ER stress (Figure 8), (b) the number of cell surface insulin 693 
receptors in unstressed cells, which can vary widely between cell types (Bar et al., 1976; Reed 694 
et al., 1977; Capeau et al., 1978), (c) the sizes of intracellular insulin receptor pools, 695 
including, for example, receptors that are transiting through the Golgi complex and receptors 696 
that are recycled at the plasma membrane at the time ER stress is induced, (d) the degree of 697 
completeness of inhibition of transport of newly synthesised receptors from the ER to the cell 698 
surface, and (e) the fraction of newly synthesised receptors that is targeted for degradation by 699 
ERAD in ER-stressed cells. For example, short periods of ER stress (< 1-2 half-lives), will 700 
not deplete receptors to levels where the response to insulin decreases measurably, while long 701 
periods (> 2 half-lives) will cause severe receptor depletion, severe loss of insulin sensitivity, 702 
and a loss in insulin responsiveness (Figure 14, B). Likewise, a ~10-fold lower plasma 703 
membrane insulin receptor population may result in measurable loss of insulin responsiveness 704 
after ER stress lasting for ~3 half-lives of the receptor at the plasma membrane, while in cells 705 
that possess ten times more receptors, ER stress has to last for several additional half-lives 706 
before similar effects on insulin responsiveness manifest (Figure 14, B and C). 707 
ER stress is present in muscle, liver, and adipose tissue of obese individuals (Özcan et al., 708 
2004; Özcan et al., 2006; Hosogai et al., 2007; Boden et al., 2008; Sharma et al., 2008; 709 
Sreejayan et al., 2008). Patients with impaired glucose tolerance or overt type II diabetes 710 
show a ~50% decrease in insulin receptors (Olefsky and Reaven, 1974; Goldstein et al., 1975; 711 
Olefsky, 1976; Olefsky and Reaven, 1977; Pagano et al., 1977; Robinson et al., 1979; 712 
Helderman and Raskin, 1980; Kobayashi et al., 1980; Kolterman et al., 1980; Kolterman et 713 
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al., 1981). This ~50% decrease in insulin receptors at the cell surface accounts for the 714 
decreased insulin sensitivity and abnormal glucose tolerance of patients with impaired 715 
glucose tolerance (Olefsky and Reaven, 1977; Pagano et al., 1977; Kolterman et al., 1980; 716 
Kolterman et al., 1981). ER stress may decrease the fraction of newly synthesised receptors 717 
that reach the plasma membrane or increase the transit time through the secretory pathway for 718 
all or some of the newly synthesised insulin receptors and through this may contribute to the 719 
decrease in the size of the steady-state cell surface population of receptors in obesity. 720 
Internalisation of the insulin receptor is necessary for its degradation (Desbuquois et al., 1982; 721 
Knutson et al., 1983; Wang et al., 1983; Draznin et al., 1984). A decrease in the insulin 722 
receptor population at the cell surface is expected to decrease its internalisation and 723 
degradation rates, and together with decreased synthesis rates may establish a new, smaller 724 
steady-state population of the receptor at the plasma membrane. Hyperinsulinemia in obesity 725 
may further aggravate decreases of the insulin receptor at the plasma membrane, because, 726 
insulin stimulates internalisation and degradation of its receptor (Kasuga et al., 1981; Knutson 727 
et al., 1982; Heidenreich et al., 1983; Ronnett et al., 1983; Freychet, 1984; Reed et al., 1984), 728 
and, in adipocytes, induces ER stress (Boden et al., 2014). Thus, the effects of ER stress on 729 
delivery of newly synthesised insulin receptors to the plasma membrane may contribute to 730 
decreased steady-state plasma membrane levels of the receptor in obesity. 731 
In conclusion, we provide evidence that ER stress requires processing of insulin receptors 732 
in the secretory pathway to inhibit signal transduction in the insulin signalling pathway 733 
(Figure 14, A). The effects of ER stress on trafficking of newly synthesised insulin receptors 734 
to the cell surface may account for the decrease in insulin receptors in patients with impaired 735 
glucose tolerance and patients with overt type II diabetes, and underlie the decreased insulin 736 
sensitivity of patients with impaired glucose tolerance. Depending on the half-lives of 737 
individual plasma membrane receptors, analogous effects of ER stress on other plasma 738 
membrane receptors and transporters may exist. 739 
MATERIALS AND METHODS 740 
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Antibodies and reagents. The mouse anti-β-actin antibody (clone 8F10-G10, cat. no. 741 
ab170325, batches GR184354-8 and GR327417-1) was purchased from Abcam (Cambridge, 742 
UK) and the rat anti-α-tubulin antibody (clone YOL1/34, cat. no. MCA78G, batch 1703) from 743 
Bio-Rad Laboratories (Hemel Hempstead, UK). Rabbit anti-phospho-T308-AKT (clone 744 
244F9, cat. no. 4056S, batches 13 and 17), anti-phospho-S473-AKT (clone D9E, cat. no. 745 
4060S, batches 16, 23, and 24), rabbit anti-AKT (clone C67E7, cat. no. 4691S, batches 11, 746 
17, and 20), rabbit anti-phospho-S63-c-Jun (clone 54B3, cat. no. 2361S, batch 7), rabbit anti-747 
c-Jun (clone 60A8, cat. no. 9165S, batch 11), rabbit anti-phospho-S51-eIF2α (cat. no. 9721S, 748 
batch 21), mouse anti-eIF2α (clone L57A5, cat. no. 2103S, batch 5), rabbit anti-insulin 749 
receptor β chain phosphorylated at Y1355 (clone 14A4, cat. no. 3026S, batch 1), rabbit anti-750 
insulin receptor β chain (clone 4B8, cat. no. 3025S, batches 8 and 10), rabbit anti-phospho-751 
Y891 (mouse)/Y896 (human)-IRS1 (cat. no. 3070S, batch 4), rabbit anti-IRS1 (clone 752 
D23G12, cat. no. 3407S, batch 6; clone D5T8J, cat no. 95816S, batch 1), rabbit anti-phospho-753 
T183-phospho-Y185-JNK (clone 81E11, cat. no. 4668S, batches 9, 12 and 15), and rabbit 754 
anti-JNK (cat. no. 9252S, batches 15 and 17) antibody were purchased from Cell Signaling 755 
Technology (Danvers, MA, USA). The mouse anti-phospho-S307 (mouse)/S312 (human)-756 
IRS1 (clone 24.6.2, cat. no. 05-1087, batch 3063387), rabbit anti-phospho-Y608 757 
(mouse)/Y612 (human)-IRS1 (cat. no. 09-432, batch 3018885), rabbit anti-phospho-Y628 758 
(mouse)/Y632 (human)-IRS1 (cat. no. 09-433, batch 3023592), rabbit anti-phospho-Y935 759 
(mouse)/941 (human)-IRS1 (cat. no. 07-848-I, batch Q2766987), mouse anti-phosphotyrosine 760 
(clone 4G10® Platinum, cat. no. 05-1050X, batches 2967319 and 3256630), and the rabbit 761 
anti-TRB3 (cat. no. 07-2160, batch 2716134) antibody were purchased from Merck Millipore 762 
(Watford, UK). Anti-insulin receptor β chain antibody (cat. no. sc-711, batch G0511) was 763 
purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and the mouse anti-764 
GAPDH antibody (clone GAPDH-71.1, cat. no. G8795, batches 092M4820V and 765 
067M4785V) from Sigma-Aldrich (Gillingham, UK). 766 
Normal rabbit IgG was purchased from Fisher Scientific (Loughborough, UK, cat. no. 767 
10312573, batch UA276761) and Santa Cruz Biotechnology (cat. no. sc-2027, batches C2712 768 
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and D1415). SureBeadsTM protein A magnetic beads were purchased from Bio-Rad 769 
Laboratories (cat. no. 1614013) and streptavidin agarose from Fisher Scientific (cat. no. 770 
10302384, batch SJ523686). Goat anti-mouse IgG(H+L)-peroxidase (cat. no. 10330974, 771 
batch OE17149612) and goat anti-rat IgG(H+L)-peroxidase (cat. no. 11889140, batch 772 
PK209942) were purchased from Fisher Scientific, and goat anti-rabbit IgG(H+L)-peroxidase 773 
from Cell Signaling Technology (cat. no. 7074S, batches 26-28). 774 
Sulphosuccinimidyl-6-(biotinamido)hexanoate [EZ-link-sulfo-NHS-biotin, cat. no. 775 
11851185] was purchased from Fisher Scientific. JNK inhibitor VIII [N-(4-amino-5-cyano-6-776 
ethoxypyridin-2-yl)-2-(2,5-dimethoxyphenyl)acetamide, cat. no. 420135-5MG], JNK 777 
inhibitor XVI [(E)-3-(4-(dimethylamino)but-2-enamido)-N-(3-methyl-4-((4-(pyridin-3-778 
yl)pyrimidin-2-yl)amino)phenyl)benzamide, cat. no. 420150-10MG], and tunicamycin (cat. 779 
no. 654380) were purchased from Merck Millipore. Endoglycosidase H (EndoH) and peptide-780 
N-glycosidase (PNGase) F were obtained from New England Biolabs (Hitchin, UK). Bovine 781 
insulin (cat. no. I0516), bovine serum albumin (BSA, cat. no. A2153), dexamethasone, 3-782 
isobutyl-1-methylxanthine, and thapsigargin (cat. no. T9033) were purchased from Sigma-783 
Aldrich. Subtilase cytotoxin (SubAB) and catalytically inactive SubAA272B were purified 784 
from Escherichia coli as described before (Paton et al., 2004; Talbot et al., 2005). siRNAs 785 
against murine INSR mRNA and Aequora victoria enhanced green fluorescent protein (eGFP) 786 
were purchased from Sigma-Aldrich and siRNAs against murine TRB3 from Fisher Scientific. 787 
siRNA sequences are listed in Table 1. 788 
Plasmids. Plasmids were maintained in Escherichia coli XL10-Gold cells (Agilent 789 
Technologies, Stockport, UK, cat. no. 200314). Standard protocols for plasmid constructions 790 
were used (Ausubel et al., 2017). Plasmid pmaxGFP was obtained from Lonza Cologne AG 791 
(Cologne, Germany). Plasmid pEGFP-N2-hINSR encodes a fusion of the human insulin 792 
receptor to eGFP (Bass et al., 2000) and was obtained from Addgene (Cambridge, MA, USA, 793 
Addgene ID 22286). Plasmid pcDNA5/FRT/TO-FV2E-INSRβ was generated by cloning the 794 
1,430 bp BsiWI-XmaI fragment of pCLFv2IRE (Cotugno et al., 2004) into BsiWI- and XmaI-795 
digested pcDNA5/FRT/TO-FV2E-C’hIRE1α (D. Cox and M. Schröder, unpubl.). Plasmid 796 
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pcDNA5/FRT/TO-MyrFV2E-INSRβ was generated by cloning the 501 bp EcoRI-XmaI 797 
fragment of pC4M-FV2E (Ariad Pharmaceuticals, Cambridge, MA, USA) into HindIII- and 798 
XmaI-digested pcDNA5/FRT/TO-FV2E-INSRβ after blunting the EcoRI and HindIII sites 799 
with Klenow enzyme. 800 
Cell culture. Wild type (WT), ire1α-/- (Lee et al., 2002), jnk1-/- jnk2-/- (Tournier et al., 2000), 801 
and traf2-/- (Yeh et al., 1997) mouse embryonic fibroblasts (MEFs) were obtained from 802 
Randal J. Kaufman (Sanford Burnham Medical Research Institute, La Jolla, CA), Roger 803 
Davis (University of Massachusetts, Worchester, MA, USA), and Tak Mak (University of 804 
Toronto, Ontario Cancer Institute, Toronto, Ontario, Canada), respectively. 3T3-F442A 805 
preadipocytes (Green and Kehinde, 1976), C2C12 myoblasts (Blau et al., 1985), HEK 293 cells 806 
(Graham et al., 1977; Harrison et al., 1977; Graham et al., 1978), and Hep G2 cells (Knowles 807 
et al., 1980) were obtained from C. Hutchison (Durham University), R. Bashir (Durham 808 
University), M. Cann (Durham University), and A. Benham (Durham University), 809 
respectively. Fao rat hepatoma cells (Deschatrette and Weiss, 1974) were obtained from 810 
Public Health England (Salisbury, UK). The Flp-In T-Rex 293 cell line was obtained from 811 
Life Technologies (Paisley, UK). All cell lines were tested for mycoplasma contamination 812 
upon receipt in the laboratory with the EZ-PCR mycoplasma test kit from Geneflow (cat. no. 813 
K1-0210, Lichfield, UK). Mycoplasma testing was repeated every ~3 months with all cells in 814 
culture at the time. Contaminated cultures were discarded. 815 
All cell lines were grown in an atmosphere of 95% (v/v) air, 5% (v/v) CO2, and 95% 816 
humidity. Fao rat hepatoma cells were grown in Roswell Park Memorial Institute (RPMI) 817 
1640 medium (Moore et al., 1967) or in Coon’s modification of Ham’s F12 medium (Coon 818 
and Weiss, 1969) containing 10% (v/v) fetal bovine serum (FBS) and 2 mM L-glutamine. 819 
Hep G2 cells were cultured in minimum essential medium (MEM) (Eagle, 1959) 820 
supplemented with 10% (v/v) FBS and 2 mM L-glutamine. All other cell lines were cultured 821 
in Dulbecco’s modified Eagle’s medium (DMEM) containing 4.5 g/l D-glucose (Morton, 822 
1970; Rutzky and Pumper, 1974), 10% (v/v) FBS, and 2 mM L-glutamine. The medium for 823 
ire1α-/- and corresponding WT MEFs was supplemented with 110 mg/l pyruvate (Lee et al., 824 
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2002). The medium for the Flp-In T-Rex 293 cells was supplemented with 100 μg/ml zeocin 825 
and 15 μg/ml blasticidin and the medium for Flp-In T-Rex 293 cells stably expressing the 826 
FV2E-insulin receptor chimera with 100 μg/ml hygromycin B and 15 μg/ml blasticidin. For 827 
immunoprecipitation of IRS1, [35S]-L-methionine pulse labelling experiments, and 828 
determination of the half-life of the insulin receptor at the cell surface 3T3-F442A cells were 829 
cultured in gelatinised tissue cultures dishes (Schröder and Friedl, 1997b). 830 
siRNAs and plasmids were transfected with INTERFERin or jetPRIME transfection 831 
reagent (Polyplus Transfection, Illkirch, France) following the manufacturer’s instructions, 832 
respectively. The stably transfected Flp-In T-Rex 293 cell lines expressing a fusion of the 833 
FV2E drug-inducible dimerisation domain (Clackson et al., 1998) to the β chain of the human 834 
insulin receptor with an N-terminal myristoylation signal were generated by transfection of 835 
the Flp-In T-Rex 293 cell line with pOG44 (Life Technologies) and pcDNA5/FRT/TO-836 
MyrFV2E-INSRβ. Selection of stably transfected clones was initiated 24 h after transfection 837 
by using 50 μg/ml hygromycin B. After two days the hygromycin B concentration was 838 
increased to 100 μg/ml. 839 
C2C12 myoblasts were differentiated into myotubes and 3T3-F442A preadipocytes into 840 
adipocytes as described before (Mihai and Schröder, 2015; Brown et al., 2016). ER stress was 841 
induced with 0.1 to 1 μM thapsigargin, 0.1 to 10 μg/ml tunicamycin, or 1 μg/ml SubAB. To 842 
stimulate cells with insulin, cells were serum-starved for 18 h, followed by addition of fresh 843 
serum-free culture medium containing 10 nM or 100 nM insulin for 5 min or 15 min. Cells 844 
were serum-starved during the last 18 h of treatments with ER stressors lasting for more than 845 
18 h. When cells were ER-stressed for shorter periods, the ER stressors were applied towards 846 
the end of the serum starvation, for example for the last 12 h of serum starvation in case of 847 
treatment with ER stressors for 12 h. Expression of the FV2E-insulin receptor chimera was 848 
induced for 24 h with 1 μg/ml tetracycline in stably-transfected Flp-In T-Rex 293 cells. The 849 
chimera was dimerised by treating cells with 100 nM AP20187 (B/B homodimeriser, TaKaRa 850 
Bio Europe, Saint-Germain-en-Laye, France, cat. no. 635058) for the times indicated in the 851 
text. 852 
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Crystal violet staining was used as a proxy to determine the number of cells remaining in 853 
culture dishes after exposure to ER stressors. Cultures were washed with phosphate-buffered 854 
saline (PBS, 4.3 mM Na2HPO4, 1.47 mM KH2PO4, 2.7 mM KCl, 137 mM NaCl, pH 7.4) at 855 
RT and stained for 10 min with 0.2% (w/v) crystal violet in 2% (v/v) ethanol at RT. After 856 
washing with tap water to remove unbound crystal violet, the crystal violet was dissolved 857 
with 1% (w/v) SDS and the absorbance at 570 nm read in a Spectramax 190 microplate reader 858 
(Molecular Devices, San Jose, CA, USA). The activity of mitochondrial redox chains was 859 
determined using thiazolyl blue tetrazolium bromide (MTT) as described previously (Mihai 860 
and Schröder, 2015), except that the absorbance at 690 nm was subtracted from the 861 
absorbance at 590 nm. Corrected MTT absorbances were normalised to the crystal violet 862 
absorbance of corresponding, identically treated cultures, and expressed relative to the 863 
absorbance of cells exposed to 0.1% (v/v) DMSO, which was arbitrarily set to 1.0. 864 
RNA extraction and reverse transcriptase PCRs. RNA was extracted and reverse transcribed 865 
as previously described (Cox et al., 2011). Protocols for quantification of splicing of XBP1 866 
have been described previously (Cox et al., 2011; Brown et al., 2016). qPCRs were run on a 867 
Rotorgene 3000 (Qiagen, Crawley, UK) using GoTaq G2 Flexi DNA polymerase (Promega, 868 
Southampton, UK, cat. no. M7801) and analysed as described before (Brown et al., 2016). 869 
Primer sequences are listed in Table 2 or have been reported before (Brown et al., 2016). 870 
Amplification of a single PCR product was confirmed by recording the melting curves after 871 
each PCR. Amplification efficiencies for all qPCRs were ~0.75 ± 0.05. Results represent the 872 
average and standard error of three technical repeats. qPCR results were confirmed by at least 873 
one other biological replicate. 874 
Cell lysis and Western blotting. Protein extracts for Western blotting except for extraction of 875 
IRS1 were produced as previously described (Brown et al., 2016). In brief, cells were washed 876 
three times with ice-cold PBS (pH 7.4) and lysed in RIPA buffer [50 mM Tris-HCl, pH 8.0 at 877 
4 °C, 150 mM NaCl, 0.5% (w/v) sodium deoxycholate, 0.1% (v/v) Triton X-100, 0.1% (w/v) 878 
SDS] containing Roche complete protease inhibitors (Roche Applied Science, Burgess Hill, 879 
UK, cat. no. 11836153001) or 10 mM EDTA, 2 mM PMSF, 6 mM 4-(2-880 
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aminoethyl)benzenesulphonyl flouride (AEBSF), 5 mM benzamidine, 10 μg/ml aprotinin, and 881 
each 1 μg/ml of antipain dihydrochloride, chymostatin, leupeptin, and pepstatin A. To inhibit 882 
protein phosphatases, PhosSTOP phosphatase inhibitors (Sigma-Aldrich, cat. no. 04 906 837 883 
001) were added when Roche complete protease inhibitors were used. When individual 884 
protease inhibitors were used, 1 mM sodium fluoride, 10 mM sodium β-glycerophosphate, 10 885 
mM sodium pyrophosphate, and 200 nM okadaic acid were included to inhibit protein serine 886 
and threonine phosphatases. To preserve protein serine, threonine, and tyrosine 887 
phosphorylation when individual protease inhibitors were used, cells were lysed in 50 mM 888 
HEPES-NaOH (pH 8.0 at 4 °C), 150 mM NaCl, 0.5% (w/v) sodium deoxycholate, 0.1% (v/v) 889 
Triton X-100, 0.1% (w/v) SDS, 6 mM EGTA, 1 mM sodium fluoride, 1 mM sodium 890 
vanadate, 10 mM sodium β-glycerophosphate, 10 mM sodium pyrophosphate, 2 mM PMSF, 891 
6 mM AEBSF, 5 mM benzamidine, 10 μg/ml aprotinin, and each 1 μg/ml of antipain 892 
dihydrochloride, chymostatin, leupeptin, and pepstatin A, 200 nM okadaic acid, 200 μM 2-893 
bromo-4-methoxyacetophenone (Arabaci et al., 1999; Arabaci et al., 2002) and 20 μM ethyl 894 
3,4-dephostatin (Watanabe et al., 2000; Suzuki et al., 2001). Protein concentrations were 895 
determined with the DC protein assay from Bio-Rad Laboratories (cat. no. 500-0116). 896 
Samples were denatured for 5 min at 100 °C after addition of 1/6 volume of 6 x SDS-PAGE 897 
sample loading buffer [350 mM Tris·HCl (pH 6.8 at RT), 30% (v/v) glycerol, 10% (w/v) 898 
SDS, 0.5 g/l bromophenol blue, 2% (v/v) β-mercaptoethanol]. 10 - 100 μg total protein were 899 
separated by SDS-PAGE (Laemmli, 1970) and transferred onto polyvinylidene difluoride 900 
(PVDF) membranes (Amersham HyBondTM-P, pore size 0.45 μm, GE Healthcare, Little 901 
Chalfont, UK, cat. no. RPN303F) by semi-dry blotting in 0.1 M Tris, 0.192 M glycine, 5% 902 
(v/v) methanol at 2 mA/cm2 for 75 min. 903 
Protein extracts for Western blotting for IRS1 and phosphorylated species of IRS1 were 904 
prepared from cells serum-starved with media lacking phenol red. Media were aspirated and 905 
cells lysed in 8 M urea, 2.5% (w/v) SDS, 50 mM Tris·HCl (pH 7.5 at 4 °C), 6 mM EDTA, 2 906 
mM PMSF, 40 mM AEBSF, 5 mM benzamidine, and 10 μM E-64. Lysates were cleared by 907 
centrifugation at 627,000 g for 2 h at 4 °C. Protein concentrations were determined with 908 
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bicinchoninic acid (Smith et al., 1985). Samples were denatured for 5 min at 70 °C after 909 
addition of 1/6 volume of 6 x SDS-PAGE sample loading buffer. 50 – 200 μg protein were 910 
separated on 7.5% SDS-PAGE gels and transferred to PVDF membranes by wet transfer in 10 911 
mM NaHCO3, 3 mM NaCO3, 0.025% (w/v) SDS (Dunn, 1986) at 50 V for 18 h (for a 1 mm 912 
thick gel) at 4 °C after equilibration of gels for 3 x 20 min at 4 °C in 10 mM NaHCO3, 3 mM 913 
NaCO3, 0.025% (w/v) SDS. 914 
Membranes were blocked for 1 h at RT or overnight at 4 °C in 5% (w/v) skimmed milk 915 
powder in TBST [20 mM Tris-HCl (pH 7.6 at RT), 137 mM NaCl, and 0.1% (v/v) Tween-20] 916 
or in TBST + 3% (w/v) skimmed milk powder when the anti-phosphotyrosine antibody was 917 
used. The anti-phospho-T308-AKT, anti-phospho-S473-AKT, anti-AKT, anti-phospho-S63-918 
c-Jun, anti-c-Jun, anti-phospho-S51-eIF2α, anti-eIF2α, anti-phospho-Y1355-insulin receptor 919 
β chain, anti-insulin receptor β chain (clone 4B8), anti-phospho-Y891 (mouse)/Y896 920 
(human)-IRS1, anti-IRS1 (clones D23G12 and D5T8J), anti-phospho-T183-phospho-Y185-921 
JNK, and anti-JNK antibodies were incubated with membranes at a 1:1,000 dilution in TBST 922 
+ 5% (w/v) BSA over night at 4°C with constant rotation. For the rabbit anti-IRS1 antibody, 923 
clone D23G12 was used to develop Western blots of cell lysates, while clone D5T8J was used 924 
to develop Western blots of immunoprecipitates of IRS1. The anti-phospho-Y608 925 
(mouse)/Y612 (human)-IRS1 and anti-phospho-Y628 (mouse)/Y632 (human)-IRS1 926 
antibodies were incubated with membranes at a 1:4,000 dilution in TBST + 5% (w/v) 927 
skimmed milk power for 2 h at RT. The anti-phospho-Y935 (mouse)/941 (human)-IRS1 928 
antibody was incubated with membranes at a 1:1,000 dilution in TBST + 5% (w/v) skimmed 929 
milk powder for 2-4 at RT or overnight at 4 °C. The anti phospho-S307 (mouse)/S312 930 
(human)-IRS1 antibody was incubated with membranes at a 1:1,000 dilution in TBST + 5% 931 
(w/v) skimmed milk powder overnight at 4 °C, and the anti-phosphotyrosine antibody at a 932 
1:1,000 dilution in TBST + 3% (w/v) skimmed milk powder for 4 h at RT. The polyclonal 933 
anti-INSR β chain antibody was used at a 1:200 dilution and the anti-TRB3 antibody at a 934 
concentration of 0.1 μg/ml in TBST + 5% (w/v) skimmed milk powder overnight at 4 °C. The 935 
anti-β-actin antibody was used at a dilution of 1:10,000 – 1:20,000 in TBST + 5% (w/v) 936 
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skimmed milk powder for 2 h at RT, the anti-GAPDH antibody at a dilution of 1:10,000 – 937 
1:30,000 in TBST + 5% (w/v) skimmed milk powder for 2 h at RT or overnight at 4 °C, and 938 
the anti-α-tubulin antibody at a dilution of 1:1,000 – 1:2,000 in TBST + 5% (w/v) skimmed 939 
milk powder for 2 h at RT. Membranes were washed four times with TBST for 5 min at RT 940 
and then probed with goat anti-mouse IgG(H+L)-peroxidase at a dilution of 1:5,000 in TBST 941 
+ 5% (w/v) skimmed milk power for 2 h at RT to detect the anti-phospho-S307 (mouse)/S312 942 
(human)-IRS1 antibody and at a dilution of 1:10,000 in TBST + 5% (w/v) skimmed milk 943 
powder for 2 h at RT to detect all other murine antibodies. Goat anti-rabbit IgG(H+L)-944 
peroxidase was used at a dilution of 1:2,000 in TBST + 5% (w/v) skimmed milk powder for 2 945 
h at RT, and goat anti-rat IgG(H+L)-peroxidase at a dilution of 1:5,000 in TBST + 5% (w/v) 946 
skimmed milk powder for 2 h at RT. Membranes were washed four times for 5 min at RT and 947 
then developed with Thermo ScientificTM PierceTM ECL Western Blotting Substrate (Fisher 948 
Scientific, cat. no. 10455145), Thermo ScientificTM PierceTM ECL 2 Western Blotting 949 
Substrate (Fisher Scientific, cat. no. 11517371) or by enhanced chemiluminescence as 950 
described before (Schröder and Friedl, 1997a). Blots were exposed to Thermo ScientificTM 951 
CL-X PosureTM film (Fisher Scientific, cat. no. 10696384) or Thermo ScientificTM CL-X 952 
PosureTM film pre-flashed with a Sensitize pre-flash unit (GE Healthcare, Little Chalfont, UK, 953 
cat. no. RPN 2051) following the manufacturer’s instructions to capture weak signals. 954 
Exposure times were adjusted based on previous exposures to obtain exposures in the linear 955 
range of the film. Films were scanned on a CanoScan LiDE 600F scanner (Canon Europa, 956 
Amstelveen, The Netherlands) or a MFC-5320 DW all-in-one printer (Brother Industries, 957 
Manchester, UK) and saved as tif files. Bands were quantified with CLIQS 1.1 (Totallab, 958 
Newcastle upon Tyne, United Kingdom). Intensities for phosphorylated proteins were 959 
normalised to the intensity of the unphosphorylated species of the protein. Changes in protein 960 
abundance are expressed relative to the loading control, β-actin, GAPDH, or α-tubulin. 961 
Variation of normaliser samples was preserved for statistical analyses by normalising all 962 
samples within one experiment to all samples with similar intensities or by normalising all 963 
samples of one experimental repeat to the normaliser samples of all repeats for this type of 964 
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experiment and using the average of these normalisations for graphing and statistical 965 
analyses. 966 
To reprobe blots for detection of nonphosphorylated proteins and loading controls, 967 
membranes were stripped using Thermo ScientificTM RestoreTM Western Blot Stripping 968 
Buffer (Fisher Scientific, cat. no. 10057103) or as described before (Armstrong et al., 2017), 969 
except that the pH of the100 mM glycine·HCl, 0.1% (v/v) Tween 20 solution was dropped to 970 
1.5 and the incubation temperature with this buffer raised to 65 °C. Membranes were then 971 
blocked with 5% (w/v) skimmed milk powder in TBST as described above. 972 
Immunoprecipitation of IRS1. Protein extracts were prepared as described under “Cell lysis 973 
and Western blotting” for extraction of IRS1. 2 mg of total protein were diluted with 50 mM 974 
Tris·HCl (pH 7.5 at 4 °C), 1% (v/v) Triton X-100, 10 mM EDTA, 0.1% (w/v) BSA to a final 975 
SDS concentration of 0.1% (w/v). All immunoprecipitations in one experiment were adjusted 976 
to the same final volume and a SDS concentration of 0.1% (w/v). Lysates were precleared 977 
with 10 μl SureBeadsTM protein A magnetic beads at 4 °C with constant, slow rotation of the 978 
tubes. Samples were centrifuged at 500 g and 4 °C for 10 s, magnetic beads collected in 979 
magnetic racks, and supernates centrifuged at 100,000 g, 4°C for 30 min and transferred to 980 
new tubes. After addition of 2 μl of anti-IRS1 antibody (clone D23G12), samples were 981 
incubated at 4 °C overnight with constant, slow rotation. Samples were then centrifuged at 982 
100,000 g, 4°C for 30 min, supernates transferred to new tubes, and immune complexes 983 
collected by addition of 30 μl SureBeadsTM protein A magnetic beads for 2 h at 4 °C with 984 
constant, slow rotation. Samples were centrifuged at 500 g and 4 °C for 10 s and 985 
immunoprecipitates collected in magnetic racks. Immunoprecipitates were washed three times 986 
with 50 mM Tris·HCl (pH 7.5 at 4 °C), 1% (v/v) Triton X-100, 10 mM EDTA, 0.1% (w/v) 987 
BSA, and once with 0.1% (w/v) BSA. The last wash solution was completely aspirated, the 988 
beads resupended in 58.3 mM Tris·HCl (pH 6.8 at RT), 10% (w/v) SDS, 8 M urea, 2.5% (v/v) 989 
β-mercaptoethanol, 0.083 g/l bromophenol blue, and denatured at 80 °C for 5 min. Denatured 990 
samples were allowed to cool to RT for 5 min, centrifuged at 17,000 g and RT for 5 min, and 991 
separated on 7.5% SDS-PAGE gels. Proteins were transferred onto PVDF membranes and 992 
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membranes blotted with anti-phosphotyrosine and anti-IRS1 (clone D5T8J) antibodies as 993 
described under “Cell lysis and Western blotting”. 994 
[35S]-L-methionine/[35S]-L-cysteine pulse labelling and immunoprecipitation of the insulin 995 
receptor. 70-80% confluent cultures were treated with 0.1 μM thapsigargin, 0.1 μg/ml 996 
tunicamycin or 0.1% (v/v) DMSO for 22.5 h. Cultures were washed twice with methionine 997 
and cysteine free culture medium pre-warmed to 37 °C and incubated with methionine and 998 
cysteine free culture medium containing 2% (v/v) dialysed FBS in the continued presence of 999 
0.1% (v/v) DMSO, 0.1 μM thapsigargin or 0.1 μg/ml tunicamycin for 20 min at 37 °C. The 1000 
medium was then replaced with fresh methionine and cysteine free culture medium 1001 
containing 2% (v/v) dialysed FBS and DMSO, thapsigargin, or tunicamycin, and [35S]-L-1002 
methionine/[35S]-L-cysteine. 3T3-F442A cells were labelled with 250 μCi of 70% [35S]-L-1003 
methionine, 25% [35S]-L-cysteine (1000 Ci/mmol, Hartmann Analytic, Braunschweig, 1004 
Germany, cat. no. SCIS-103) and Hep G2 cells with 125 μCi of 70% [35S]-L-methionine, 25% 1005 
[35S]-L-cysteine (1000 Ci/mmol) per 10 cm dish for 1 or 8 h. Dishes were placed on ice, the 1006 
medium aspirated and cultures washed three times with ice-cold PBS (pH 7.4), and lysed in 1007 
125 μl of ice-cold 50 mM HEPES-NaOH (pH 7.5 at 4 °C), 150 mM NaCl, 0.5% (w/v) sodium 1008 
deoxycholate, 0.1% (v/v) Triton X-100, 0.1% (w/v) SDS, 10 mM EDTA, 2 mM PMSF, 6 mM 1009 
AEBSF, 5 mM benzamidine, 10 μg/ml aprotinin, and each 1 μg/ml of antipain 1010 
dihydrochloride, chymostatin, leupeptin, and pepstatin A/10 cm dish. Lysates were cleared by 1011 
centrifugation at 16,100 g, 4 °C for 30 min, and the protein concentration of lysates 1012 
determined with the Bio-Rad Laboratories DC protein assay. For each immunoprecipitation 1013 
2.4 mg of total cell protein were diluted to a final concentration of 4.8 mg/ml with ice-cold 50 1014 
mM HEPES-NaOH (pH 7.5 at 4 °C), 150 mM NaCl, 10 mM EDTA, 0.5% (w/v) sodium 1015 
deoxycholate, 0.1% (v/v) Triton X-100, 0.1% (w/v) SDS. 3T3-F442A cell lysates were 1016 
precleared by incubation with 6.24 μl 100 ng/μl of normal rabbit IgG and 60 μl of 1017 
SureBeadsTM protein A magnetic beads for 2 h at 10 °C with overhead rotation. For Hep G2 1018 
cell lysates, 3.12 μl 100 ng/μl of normal rabbit IgG and 30 μl of SureBeadsTM protein A 1019 
magnetic beads were used in the preclearing step. SureBeadsTM protein A magnetic beads 1020 
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were collected in magnetic racks, supernates centrifuged at 16,100 g, 4 °C for 15 min, and 1021 
supernates transferred to new tubes. 6 μl of 52 ng/μl anti-insulin receptor β chain antibody 1022 
(clone 4B8) or 3.12 μl 100 ng/μl normal rabbit IgG were added and samples incubated 1023 
overnight at 10 °C with overhead rotation. Samples were centrifuged at 16,100 g, 4 °C for 15 1024 
min, supernates transferred to new tubes, and 30 μl SureBeadsTM protein A magnetic beads 1025 
added to collect immune complexes while incubating samples for 2 h at 10 °C with overhead 1026 
rotation. Immune complexes were collected in magnetic racks. For immunoprecipitation of 1027 
the insulin receptor from 3T3-F442A cell lysates, immunoprecipitates were washed three 1028 
times with ice-cold 50 mM HEPES-NaOH (pH 7.5 at 4 °C), 500 mM NaCl, 10 mM EDTA, 1029 
0.5% (w/v) sodium deoxycholate, 1% (v/v) Triton X-100, 0.1% (w/v) SDS, 1 M urea, and 1030 
once with ice-cold water. For immunoprecipitation of the insulin receptor from Hep G2 cell 1031 
lysates, immunoprecipitates were washed three times with ice-cold 50 mM HEPES-NaOH 1032 
(pH 7.5 at 4 °C), 2 M NaCl, 10 mM EDTA, 0.5% (w/v) sodium deoxycholate, 0.1% (v/v) 1033 
Triton X-100, 0.1% (w/v) SDS, and once with ice-cold water. The water was completed 1034 
aspirated, immunoprecipitates resuspended in 58.3 mM Tris·HCl (pH 6.8 at RT), 5% (v/v) 1035 
glycerol, 10% (w/v) SDS, 2.5% (v/v) β-mercaptoethanol, 0.083 g/l bromophenol blue, and 1036 
denatured at 100 °C for 5 min. Denatured samples were allowed to cool to RT for 5 min, 1037 
centrifuged at 17,000 g, RT for 15 min, and separated on 7.5% SDS-PAGE gels, in which the 1038 
SDS concentration had been raised to 1.25 g/l in both the stacking and separating gels. Gels 1039 
were washed three times with water for 15 min at RT and dried for autoradiography with 1040 
filter paper packing on a GelAir Drying System (Bio-Rad Laboratories, cat. no. 1651772) 1041 
following the manufacturer’s instructions (Krishnan and Nguyen, 1990). Gels were exposed 1042 
to Kodak storage phosphor SD230 screens for 12 – 16 d and scanned on a Typhoon 9400 1043 
system (GE Healthcare). The abundance of 35S-labelled α-β proreceptors was expressed 1044 
relative to one randomly selected sample treated with 0.1% (v/v) DMSO. 1045 
Measurement of protein synthesis rates by [35S]-L-methionine/[35S]-L-cysteine pulse 1046 
labelling. Cells were treated with 0.1% (v/v) DMSO, 0.1 μM thapsigargin, or 0.1 μg/ml 1047 
tunicamycin and labelled with 70% [35S]-L-methionine, 25% [35S]-L-cysteine and protein 1048 
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lysates prepared as described for “[35S]-L-methionine/[35S]-L-cysteine labelling and 1049 
immunoprecipitation of the insulin receptor”, except that cells were labelled in 6 well plates 1050 
with 0.35 μCi of 70% [35S]-L-methionine, 25% [35S]-L-cysteine (1000 Ci/mol) per cavity for 1051 
30 min, and that lysates were prepared with 50 μl of lysis buffer per cavity. 50 μg of total 1052 
protein were denatured after addition of 1/6 volume of 6 x SDS-PAGE sample loading buffer 1053 
and heating to 100 °C for 5 min and resolved on 12% SDS-PAGE gels. Gels were stained 1054 
with 0.1% (w/v) Coomassie Brilliant Blue R-250 in 50% (v/v) methanol, 10% (v/v) acetic 1055 
acid for 30 min at RT, destained in 8% (v/v) acetic acid, 7% (v/v) methanol at RT, washed 1056 
three times with water for 15 min at RT, and dried for autoradiography with filter paper 1057 
packing as described above. Gels were exposed to Fujifilm BAS-IP multipurpose standard 1058 
(MS) storage phosphor screens for 4 d or 16 d and scanned on a Typhoon 9400 system (GE 1059 
Healthcare) to record the 35S autoradiography signal and on a MFC-5320 DW all-in-one 1060 
printer to record images of the Coomassie Brilliant Blue R-250-stained gels. Protein synthesis 1061 
rates were expressed relative to the average of all cultures for one cell line treated with 0.1% 1062 
(v/v) DMSO. 1063 
To measure [35S]-L-methionine/[35S]-L-cysteine incorporation rates by scintillation 1064 
counting of TCA precipitates, 50 μg of protein lysate were added to 100 μl 1 mg/ml BSA on 1065 
ice, followed by 1 ml of ice-cold 10% (w/v) TCA. Samples were incubated on ice for 30 min. 1066 
TCA precipitates were collected on GF/C glass fibre filters (GE Healthcare, cat. no. 1822-1067 
025) prewetted with ice-cold 10% (w/v) TCA. The TCA precipitates were washed twice with 1068 
ice-cold 10% (w/v) TCA, twice with ethanol, and allowed to dry at RT. Precipitated 1069 
radioactivity was measured by scintillation counting in a Tri-Carb 2200 CA Liquid 1070 
Scintillation Analyzer (Canberra Packard, Pangbourne, UK) in 20 ml plastic scintillation vials 1071 
with 10 ml Ecoscint A (National Diagnostics, Hessle, UK). Counts per minute were converted 1072 
into disintegrations per minute by using a prerecorded 35S quench curve for the transformed 1073 
spectral index of the external standard constructed by adding increasing amounts of 1074 
chloroform to vials each containing 1·103 Bq of 70% [35S]-L-methionine, 25% [35S]-L-1075 
cysteine (1000 Ci/mol) in a total volume of 10 ml Ecoscint A/chloroform mixtures. 1076 
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Measurement of the half-life of the insulin receptor at the cell surface. 70-80% confluent 1077 
cultures were washed three times with ice-cold PBS (pH 8.0; 10 mM Na2HPO4, 2.0 mM 1078 
KH2PO4, 2.7 mM KCl, 137 mM NaCl), labelled for 5 min at 4 °C in PBS (pH 8.0), 1 g/l D-1079 
glucose, 100 mg/l CaCl2, 100 mg/l MgCl2, 36 mg/l sodium pyruvate, 2 mM 1080 
sulphosuccinimidyl-6-(biotinamido)hexanoate, washed three times with PBS (pH 8.0), 100 1081 
mM glycine at RT, three times with PBS (pH 7.4) at RT, replenished with culture medium 1082 
containing 0.1% (v/v) DMSO, 0.3 μM thapsigargin, 1 μg/ml tunicamycin, or 1 μg/ml SubAB 1083 
prewarmed to 37 °C, and incubated at 37 °C, 5% (v/v) CO2, and 95% relative humidity for up 1084 
to 72 h. To prepare protein lysates, cultures were placed on ice, washed three times with ice-1085 
cold PBS (pH 7.4), and lysed in RIPA buffer containing 10 mM EDTA, 2 mM PMSF, 6 mM 1086 
AEBSF, 5 mM benzamidine, 10 μg/ml aprotinin, and each 1 μg/ml of antipain, chymostatin, 1087 
leupeptin, and pepstatin A. Protein concentrations were determined with the Bio-Rad 1088 
Laboratories DC protein assay. Biotinylated proteins were collected with 10 μl streptavidin-1089 
agarose beads from 100 μg total protein for 3T3-F442A cells, 200 μg total protein for C2C12 1090 
cells, and 50 μg total protein for Hep G2 cells for 1 h at 4 °C. The streptavidin-agarose beads 1091 
were washed once with ice-cold 10 mM HEPES (pH 7.5 at 4 °C), 1% (v/v) Triton X-100, 10 1092 
mM EDTA, twice with ice-cold 10 mM HEPES (pH 7.5 at 4 °C), 1% (v/v) Triton X-100, 10 1093 
mM EDTA, 6 M urea, and once with ice-cold water. The water was completed aspirated and 1094 
beads resuspended in 15 μl of 6 x SDS-PAGE sample loading buffer. After denaturation at 1095 
100 °C for 5 min, purified proteins were resolved on 10% SDS-PAGE gels, transferred by 1096 
semi-dry blotting onto PVDF membranes, developed with anti-insulin receptor β chain (clone 1097 
4B8) and anti-GAPDH antibodies, and chemiluminescence signals quantified as described 1098 
under “Cell lysis and Western blotting”. To determine the half-life of the insulin receptor at 1099 
the cell surface, the intensity of biotinylated insulin receptors purified on streptavidin-agarose 1100 
beads immediately after labelling of cells with sulphosuccinimidyl-6-(biotinamido)hexanoate 1101 
(‘0 h time point’) was arbitrarily set to 1.0. Levels of biotinylated insulin receptors purified 6 1102 
h, 12 h, 24 h, 36 h, 48 h, and 72 h after labelling of cells with sulphosuccinimidyl-6-1103 
(biotinamido)hexanoate were expressed relative to the level of biotinylated insulin receptors 1104 
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purified at the 0 h time point. Half-lives were calculated from the slopes of linear decay 1105 
curves of the natural logarithm of the relative abundance of biotinylated insulin receptors over 1106 
time. For each condition, half-lives were determined in at least three independent 1107 
experiments. Runs tests (Wald and Wolfowitz, 1940) did not reveal significant deviations 1108 
form a linear relationship between the natural logarithm of the relative abundance of 1109 
biotinylated insulin receptors and the time after the labelling reaction. Pilot experiments 1110 
established that labelling of surface exposed insulin receptors is maximal and that 1111 
biotinylation pull-down reactions are quantitative under the conditions described above (data 1112 
not shown). 1113 
Endo H and PNGase F digests. 8 μg of protein were denatured in 0.5% (w/v) SDS, 40 mM 1114 
DTT at 100°C for 10 min. Samples were then incubated with 1000 U of Endo H in 50 mM 1115 
sodium citrate, pH 5.5 (at 25 °C) at 37°C for 2 h. For PNGase F digests denatured samples 1116 
were incubated with 1000 U of PNGase F in 50 mM sodium phosphate pH 7.5 (at 25 °C), 1% 1117 
(v/v) NP-40 at 37 °C for 2 h. 1118 
Fluorescence microscopy. Images of GFP-tagged insulin receptors expressed in HEK 293 1119 
cells were taken on a Zeiss ApoTome microscope (Carl Zeiss, Cambridge, UK) equipped with 1120 
a Zeiss 63x Plan-APOCHROMAT Oil PH3 objective with a numerical aperture of 1.4 18 h 1121 
after induction of ER stress with 1 μg/ml tunicamycin or 1 μg/ml SubAB. The cell membrane 1122 
was visualised by staining cells for 5 min at RT with 5 μg/ml CellMask Deep Red (Life 1123 
Technologies). GFP fluorescence was observed using a band pass (BP) 450-490 filter (Carl 1124 
Zeiss, FITC/GFP, filter set 9, cat. no. 488009-000) and a long pass (LP) 515 filter. CellMask 1125 
Deep red fluorescence was observed using a BP546/12 filter (Carl Zeiss, Rhodamine, filter set 1126 
15, cat. no. 488015-0000) and a LP 590 filter. To quantify colocalisation of the GFP-tagged 1127 
insulin receptors and CellMask Deep Red signals, individual cells were defined as regions of 1128 
interest (ROI) in Image J 1.47 (Schneider et al., 2012), and background-corrected for the 1129 
intracellular fluorescence of CellMask Deep Red using the Background Subtraction from the 1130 
ROI plug-in. The Pearson correlation coefficient between the INSR-GFP and CellMask Deep 1131 
Red Fluorescence was determined in individual cells using the Colocalization Test plug-in 1132 
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and Costes’ image randomization (Costes et al., 2004) and a point spread function (PSF) 1133 
width of 0.453 μm as a quantitative measure of colocalization of both fluorescence signals 1134 
(Manders et al., 1992; Manders et al., 1993). 1135 
Statistical calculations. Experimental data are presented as means and standard errors. For 1136 
composite parameters, errors were propagated using the law of error propagation for random, 1137 
independent errors (Ku, 1966). Data were analysed for normality using the D’Agostino-1138 
Pearson omnibus normality test (D'Agostino and Pearson, 1973) or Shapiro-Wilk test 1139 
(Shapiro and Wilk, 1965), equality of variances (homoscedasticity) using the Brown-Forsythe 1140 
test (Brown and Forsythe, 1974), and, for additivity of means, treatment effects, and errors 1141 
using Tukey’s test (Tukey, 1949b; Little and Hills, 1972) before ordinary one- or two-way 1142 
analysis of variance (ANOVA). Heteroscedastic data were transformed before ANOVA 1143 
(Little and Hills, 1972) or examined by Welch’s test (Welch, 1947) and a Games-Howell post 1144 
hoc test (Games and Howell, 1976) or Dunnett’s T3 multiple comparisons test (Dunnett, 1145 
1980). Kruskal-Wallis one-way ANOVA on ranks (Kruskal and Wallis, 1952) with Dunn’s 1146 
post-hoc test (Dunn, 1964) was used to analyse data that are not normally distributed or 1147 
heteroscedastic. Transformed data were reexamined for normality, equality of variances, and 1148 
additivity. In all analyses, a familywise p value of < 0.05 was considered statistically 1149 
significant. Brown-Forsythe tests for equality of variances, Tukey’s test for additivity, and 1150 
runs tests (Wald and Wolfowitz, 1940) were performed in Microsoft Excel 2010 or Microsoft 1151 
365 Excel (Microsoft Corporation, Redmond, WA, USA) using the Real Statistics plug-in 1152 
(http://www.real-statistics.com/). All other statistical calculations, linear and non-linear 1153 
regressions were performed in GraphPad Prism 6.0.7 or 8.4.3 (GraphPad Software, La Jolla, 1154 
CA, USA). 1155 
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Table 2. Oligodeoxynucleotides. 1757 
Name Purpose Sequence 
H8962 TRB3 real time PCR, forward TTTGGAACGAGAGCAAGGCA 
H8963 TRB3 real time PCR, reverse CCACATGCTGGTGGGTAGG 
H9044 INSR real time PCR, forward CTTCTCTTCCGTGTCTATGG 
H0945 INSR real time PCR, reverse GACCATCTCGAAGATAACCA 
 1758 
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FIGURE LEGENDS 1760 









 myotubes were serum-1762 
starved for 18 h and treated with the indicated concentrations of thapsigargin (Tg), 1763 
tunicamycin (Tm), 1 μg/ml SubAB, or 1 μg/ml catalytically inactive SubA
A272
B during the 1764 
last 1-8 h of serum starvation and then stimulated with 100 nM insulin for 15 min where 1765 
indicated. Cell lysates were analysed by Western blotting. Quantification of phosphorylation 1766 
of AKT on (B) T308 and (C) S473. Bars represent standard errors (n = 5 for S473 1767 
phosphorylation of AKT at 8 h in unstressed, insulin-stimulated cells, n = 6 for all other 1768 
unstressed, insulin-stimulated samples, and n = 3 for all other treatments). p values for 1769 
comparison of ER-stressed samples and samples not stimulated with 100 nM insulin to 1770 
samples stimulated with 100 nM insulin were calculated by ordinary two-way ANOVA with 1771 
Dunnett’s multiple comparisons test (Dunnett, 1955, 1964). (D) Detection of XBP1 splicing 1772 
by reverse transcriptase PCR. PCR products derived from unspliced (u) and spliced (s) XBP1 1773 
mRNA are indicated by arrows. β-Actin (ACTB) was used as a loading control. (E-F) 1774 
Induction of TRB3 in C2C12 cells by ER stress. C2C12 cells were treated with 300 nM 1775 
thapsigargin, 1 μg/ml tunicamycin, SubAB (labelled ‘WT’), or SubAA272B (labelled ‘mt.’) for 1776 
(E) 4 h and (F) 8 h. TRB3 mRNA levels were determined by reverse transcriptase-qPCR and 1777 
standardised to the loading control ACTB. Bars represent standard errors (n = 2 for the 1778 
samples treated with thapsigargin or tunicamycin for 8 h, n = 3 for all other samples). p values 1779 
for comparison of treated samples to the untreated sample (‘-‘) were calculated by ordinary 1780 
two-way ANOVA with Dunnett’s multiple comparisons test taking data shown in Fig. 10F 1781 
into account. Abbreviations: ns – not significant, * or # - p < 0.05, ** or ## - p < 0.01, *** or 1782 
### - p < 0.001, and ****or #### - p < 0.0001. 1783 
Figure 2. Acute ER stress does not inhibit phosphorylation of AKT on S473 stimulated with 1784 




 myotubes, and (C) Hep G2 cells 1785 
were serum-starved for 18 h and treated with 0.3 μM thapsigargin, 1 μg/ml tunicamycin, 1 1786 
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μg/ml SubAB, or 1 μg/ml catalytically inactive SubA
A272
B during the last 30 min of serum 1787 
starvation and then stimulated with 10 nM insulin for 15 min where indicated. Cell lysates 1788 
were analysed by Western blotting. Bars represent standard errors (n = 3). p values for 1789 
comparison of ER-stressed samples and samples not stimulated with 10 nM insulin to samples 1790 
stimulated with 10 nM insulin were calculated by ordinary two-way ANOVA with Dunnett’s 1791 
multiple comparisons test. 1792 
Figure 3. Acute ER stress does not inhibit insulin-stimulated phosphorylation of IRS1 at four 1793 
specific tyrosine phosphorylation sites in C2C12 myotubes. Tyrosine phosphorylation at (A) 1794 
Y608, (B) Y628, (C) Y891, and (D) Y935 was analysed by Western blotting. C2C12 myotubes 1795 
were serum-starved for 18 h before exposure to 1 μM thapsigargin for 10, 20, or 30 min (left 1796 
side of figure panels) or to 0.1, 1.0, or 10 μg/ml tunicamycin for 30 min (right side of figure 1797 
panels), followed by stimulation with the indicated concentrations of insulin for 5 min in the 1798 
continued presence of thapsigargin or tunicamycin. Bars represent standard errors (n = 3). p 1799 
values for comparison of effects of thapsigargin or tunicamycin within one insulin 1800 
concentration and for comparison of effects of different insulin concentrations were 1801 
calculated by ordinary two-way ANOVA with Tukey’s multiple comparisons test (Tukey, 1802 
1949a). Abbreviation: α-Tub – α-tubulin. 1803 
Figure 4. Acute ER stress does not inhibit insulin-stimulated tyrosine phosphorylation of 1804 
IRS1. Serum-starved cells were exposed to (A) 1 μM thapsigargin or (B) 10 μg/ml 1805 
tunicamycin for 30 min, followed by stimulation with the indicated concentrations of insulin 1806 
for 5 min in the continued presence of thapsigargin or tunicamycin. After 1807 
immunoprecipitation of IRS1, Western blots were probed with an anti-phosphotyrosine (‘pY’) 1808 
and an anti-IRS1 antibody. Bars represent standard errors (n = 3 for thapsigargin-treated 1809 
C2C12 myotubes, n = 4 for thapsigargin-treated 3T3-F442A cells and tunicamycin-treated Hep 1810 
G2 cells, n = 5 for tunicamycin-treated 3T3-F442A cells and thapsigargin-treated Hep G2 1811 
cells, and n = 6 for tunicamycin-treated C2C12 myotubes). p values for comparison of effects 1812 
of thapsigargin or tunicamycin within one insulin concentration and for comparison of effects 1813 
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of different insulin concentrations were calculated by ordinary two-way ANOVA with 1814 
Tukey’s multiple comparisons test. For 3T3-F442A cells and Hep G2 cells treated with 1815 
tunicamycin data were square root transformed before statistical analyses. 1816 
Figure 5. ER stress does not elicit IRS1 S307/S312 phosphorylation. (A, B) Serum-starved 1817 
3T3-F442A cells, (C, D) C2C12 myotubes, and (E, F) Hep G2 cells were treated with 1 μM 1818 
thapsigargin or 5 μg/ml anisomycin (ANI) for the indicated times. (A, C, and E) Cell lysates 1819 
were analysed by Western blotting. (B, D, and F) Quantification of the Western blots shown 1820 
in panels A, C, and E. Bars represent standard errors (n = 3). p values for comparison of every 1821 
sample to every other sample were calculated by ordinary one-way ANOVA with Tukey’s 1822 
multiple comparisons test. Anisomycin-treated samples are positive controls in the phospho-1823 
S307/S312-IRS1 Western blots. 1824 
Figure 6. Depletion of insulin receptors coincides and correlates with decreased AKT S473 1825 




 myoblasts and suffices to decrease AKT S473 1826 




 cells were treated with the indicated concentrations 1827 
of thapsigargin, tunicamycin, 1 μg/ml SubAB or 1 μg/ml SubAA272B for 12 - 24 h before 1828 
stimulation with 100 nM insulin for 15 min. Cell lysates were analysed by Western blotting 1829 
for pS473-AKT, total AKT, the insulin receptor (INSR), and GAPDH. Bands representing the 1830 
α-β proreceptor, the unglycosylated α-β proreceptor, and the β chain of the mature insulin 1831 
receptor are labelled α-β, α-β – N, and β, respectively. (B) Quantification of the 1832 
phosphorylation of AKT on S473 (’pS473-AKT’) and of the relative abundance of β chains of 1833 
the insulin receptor (‘β chain’). Bars represent standard errors (AKT phosphorylation at S473: 1834 
n = 6 for cells stimulated with 100 nM insulin at the 12 h time points, n = 7 and n = 9 for the 1835 
18 and 24 h time points, for all other samples n = 3 for the 12 h time point, n = 4 for the 18 h 1836 
time point and n = 5 for the 24 h time point; relative abundance of β chains: n = 9 for cells 1837 
stimulated with 100 nM insulin at the 12 h time point, n = 10 for the 18 h time point, and n = 1838 
12 for the 24 h time point, 12 h: n = 5 for the unstimulated cells and the insulin-stimulated 1839 
cells treated with 0.1 mM thapsigargin, n = 3 for the cells treated with SubAA272B, and n = 4 1840 
 70 
for all other samples, 18 h: n = 6 for the unstimulated cells, n = 3 for cells treated with 1841 
SubAA272B, and n = 5 for all other samples, 24 h: n = 6 for all samples). Phosphorylation of 1842 
AKT at S473 and the relative abundance of β chains are expressed relative to unstressed cells 1843 
that were stimulated with 100 nM insulin for 15 min. p values for comparison of ER-stressed 1844 
to unstressed samples were calculated using ordinary two-way ANOVA with Dunnett’s 1845 
multiple comparisons test on the original data for AKT phosphorylation at S473 and square 1846 
root-transformed data for the relative abundance of β chains. (C) Correlation of insulin-1847 
stimulated AKT phosphorylation with insulin receptor β chains (r2 = 0.80, two-tailed p < 1848 
0.0001 for a significantly non-zero slope, and p > 0.05 for deviation from linearity calculated 1849 
by a runs test, n = 27). Dotted lines represent the 95% confidence interval of the linear 1850 
regression line. The relative phosphorylation of AKT at S473 shown in panel (B) was plotted 1851 
against the relative abundance of β chains shown in panel (B). (D) Steady-state INSR mRNA 1852 
levels in C2C12 cells transfected with 50 nM of the indicated siRNAs for 24, 48, or 72 h. Bars 1853 
represent standard errors (n = 3). p values for comparison of cells transfected with the three 1854 
INSR siRNAs to the cells transfected with the eGFP siRNA were calculated with an ordinary 1855 
two-way ANOVA with Tukey’s multiple comparisons test. Differences in INSR mRNA levels 1856 
between different INSR siRNAs within individual time points or between different time points 1857 
for individual siRNAs are not significant. (E) siRNA-mediated knock-down of expression of 1858 
the insulin receptor inhibits insulin-stimulated phosphorylation of AKT. Serum-starved C2C12 1859 
cells were stimulated with insulin 48 h after transfection of 50 nM of the indicated siRNAs. 1860 
Two unspecific bands are marked with an asterisk (‘*’). 1861 
Figure 7. Inhibition of insulin receptor synthesis at the transcriptional or translational level 1862 
cannot fully account for decreased insulin-stimulated AKT S473 phosphorylation. (A) INSR 1863 
mRNA levels measured by reverse transcriptase-qPCR in C2C12 cells treated with 300 nM 1864 
thapsigargin, 1 μg/ml tunicamycin, or 1 μg/ml SubAB for 24 h. Bars represent standard errors 1865 
(n = 3). p values for comparison of ER-stressed samples to unstressed samples were 1866 
calculated using ordinary one-way ANOVA with Dunnett’s multiple comparisons test. (B-D) 1867 
Protein synthesis rates in (B) 3T3-F442A (n = 8), (C) C2C12 (n = 8), and (D) Hep G2 cells (n 1868 
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= 4) treated with 0.1 μM thapsigargin or 0.1 μg/ml tunicamycin for 24 h measured by 1869 
incorporation of [35S]-L-methionine into protein. Protein synthesis rates were determined as 1870 
TCA-precipitable counts standardised to total protein. Bars represent standard errors. p values 1871 
were calculated by ordinary one-way ANOVA with Tukey’s multiple comparisons test. (E) 1872 
Protein synthesis rates in cells treated for 24 h with 0.1 μM thapsigargin or 0.1 μg/ml 1873 
tunicamycin measured by storage phosphor analysis of [35S]-L-methionine incorporation into 1874 
protein. For each cell line the storage phosphor image of the SDS-PAGE gel is shown to the 1875 
left, and an image of the Coomassie Brilliant Blue R250-stained gel is shown to the right. 1876 
Quantification of [35S]-L-methionine incorporation into protein, expressed as the volume of 1877 
the 35S storage phosphor signal relative to the Coomassie Brilliant Blue R250 staining 1878 
intensity is shown in the bar graphs below the gel images. Bars represent standard errors (n = 1879 
8). p values were calculated by ordinary one-way ANOVA with Tukey’s multiple 1880 
comparisons test. (F) Phosphorylation of eIF2α at S51 in 3T3-F442A cells (n = 13 for 0.5 h 1881 
and n = 12 for 24 h), C2C12 cells (n = 21), and Hep G2 cells (n = 13 for 0.5 h and n = 8 for 24 1882 
h) exposed for 0.5 or 24 h to 0.1 μg/ml tunicamycin or 0.1 μM thapsigargin. The treatment 1883 
with 0.1 μM thapsigargin for 0.5 h is a positive control for the pS51-eIF2α Western blots. 1884 
Bars represent standard errors. For 3T3-F442A cells, p values were calculated by Welch’s 1885 
ANOVA with Dunnett’s T3 multiple comparisons test. For C2C12 and Hep G2 cells, p were 1886 
calculated by a Kruskal-Wallis test with Dunn’s multiple comparisons test. (G) 1887 
Immunoprecipitation of the insulin receptor after a 1 h label with [35S]-L-methionine in 3T3-1888 
F442A cells. Thapsigargin was used at 0.1 μM and tunicamycin at 0.1 μg/ml. Abbreviations: 1889 
Mock – immunoprecipitation with non-immune IgG. 1st – immunoprecipitation of the insulin 1890 
receptor after an 8 h labelling period. 2nd – immunoprecipitation of insulin receptors 1891 
remaining in the supernate of the 1st immunoprecipitation. #1, #2, and #3 indicate three 1892 
biological repeats. (H) Quantification of newly synthesised α-β proreceptors in 3T3-F442A 1893 
cells (left) and Hep G2 cells (right). Bars represent standard errors (n = 3). p values were 1894 
calculated by ordinary one-way ANOVA with Tukey’s multiple comparisons test. 1895 
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Figure 8. ER stress does not increase turnover of insulin receptors at the cell surface. (A, C, 1896 
and E) Pull-down of cell surface proteins with streptavidin-agarose after biotinylation with 1897 
the cell-impermeable biotinylation reagent sulphosuccinimidyl-6-(biotinamido)hexanoate 1898 
from (A) 3T3-F442A, (C) C2C12, and (E) Hep G2 cells. Cell extracts were prepared 0 – 72 h 1899 
after labelling of cell surface proteins. Biotinylated proteins were isolated with streptavidin-1900 
agarose, separated by SDS-PAGE, and Western-blotted for the insulin receptor and GAPDH. 1901 
‘-‘ refers to a pull-down reaction with unlabelled cell lysates. The arrows indicate that the 1902 
supernate of the pull-down reaction with the labelled 0 h sample was subjected to a second 1903 
pull-down with streptavidin-agarose. The lanes labelled ‘Input’ serve as a positive control for 1904 
the GAPDH Western blots on precipitates of the streptavidin-agarose pull down reactions and 1905 
themselves were not subjected to pull-down with streptavidin-agarose. The rows labelled 1906 
‘Input’ show Western blots for GAPDH on equal amounts of input protein for the 1907 
streptavidin-agarose pull-down assays. The graphs show plots of the natural logarithm of the 1908 
abundance of biotinylated insulin receptors over time, the line of linear regression 1909 
(uninterrupted line), and the 95% confidence interval of the line of linear regression (dotted 1910 
lines). (B, D, and F) Comparison of the half-life, t1/2, of the insulin receptor at the cell surface 1911 
of (B) 3T3-F442A (n = 3), (D) C2C12 (n = 3), and (F) Hep G2 (untreated n= 7, 0.3 μM 1912 
thapsigargin n = 8, and 1 μg/ml tunicamycin and SubAB n = 5) cells. Half-lives were 1913 
calculated from the slopes of linear regression lines obtained from plots of the natural 1914 
logarithm of the abundance of biotinylated insulin receptors over time. Bars represent 1915 
standard errors. p values were calculated by ordinary one-way ANOVA with Tukey’s 1916 
multiple comparisons test. 1917 
Figure 9. Unprocessed α-β proreceptors accumulate in the ER of ER-stressed cells. (A) 1918 
Quantification of the relative abundance of α-β precursors of the insulin receptor in C2C12 1919 
cells exposed to the indicated concentrations of thapsigargin, tunicamycin, 1 μg/ml SubAB, or 1920 
SubAA272B for 24 h. Bars represent standard errors (n = 12 for unstressed, insulin-stimulated 1921 
cells, n = 5 for the samples treated with 0.3 μM thapsigargin and SubAA272B, and n = 6 for all 1922 
other samples). p values for comparison of ER-stressed samples and samples not stimulated 1923 
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with 100 nM insulin to the sample stimulated with 100 nM insulin were calculated using 1924 
ordinary two-way ANOVA with Dunnett’s multiple comparisons test including data for 12 h 1925 
(n = 8 for unstressed, insulin-stimulated cells, n = 4 for all other samples) and 18 h (n = 10 for 1926 
unstressed, insulin-stimulated cells, n = 5 for all other samples) time points. (B) Endo H 1927 
digest of cell lysates prepared from C2C12 cells exposed to 1 μg/ml SubAB, 0.3 μM 1928 
thapsigargin, or 1 μg/ml tunicamycin. (C) Quantification of the relative abundance of β chains 1929 
and α-β proreceptors from panel B. (D) The mature β chain of the insulin receptor carries 1930 
Endo H sensitive N-linked oligosaccharides. Endo H and PNGase F digests of unstressed 1931 
C2C12 cells were immunoblotted for the β chain of the insulin receptor. ‘#’ indicates an 1932 
unspecific band. (E) Steady-state insulin receptor levels in untreated HEK 293 cells or HEK 1933 
293 cells treated for 18 h with 0.1 μg/ml tunicamycin, 1 μg/ml SubAB or SubAA272B. (F) 1934 
MTT activity of untreated HEK 293 cells and HEK 293 exposed for 18 h to 300 nM 1935 
thapsigargin, 1 μg/ml tunicamycin, or 1 μg/ml SubAB. Bars represent standard errors (n = 3). 1936 
p values for comparison of treated samples to the untreated sample were calculated by 1937 
ordinary one-way ANOVA with Dunnett’s multiple comparisons test. (G) Localisation of 1938 
GFP-tagged insulin receptors in transiently transfected HEK 293 cells after 18 h treatment 1939 
with 1 μg/ml tunicamycin or 1 μg/ml SubAB. Scale bar - 10 μm. (H) Average Pearson’s 1940 
correlation coefficient robs between the GFP-tagged insulin receptor and CellMask Deep Red 1941 
fluorescence determined from eleven randomly chosen cells. Bars represent standard errors (n 1942 
= 10 for tunicamycin-treated samples and n = 11 for all other samples). p values for 1943 
comparison of the treated to the untreated samples were calculated with an ordinary two-way 1944 
ANOVA using Tukey’s multiple comparisons test on arcsine-transformed data. The Pearson 1945 
correlation coefficients for the randomised images are -0.13 ± 0.08, -0.13 ± 0.07, and -0.33 ± 1946 
0.07 for the untreated, tunicamycin-, and SubAB-treated cells and are significantly different 1947 
(p < 0.001, calculated with a two-way ANOVA using Šidák’s correction for multiple 1948 
comparisons (Šidák, 1967) on arcsine-transformed data) from the corresponding Pearson 1949 
correlation coefficients for the non-randomised images. 1950 
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Figure 10. Bypass of the ER in insulin receptor synthesis abrogates ER stress-induced insulin 1951 
resistance. (A) Schematic of the WT insulin receptor, the myristoylated FV2E-insulin receptor 1952 
chimera, and activation of the chimera by AP20187. Black boxes represent the signal peptide 1953 
sequence and transmembrane domain of the insulin preproreceptor, striped boxes the protein 1954 
tyrosine kinase domain of the insulin receptor, and checkered boxes individual FV domains. 1955 
Disulphide bonds that link α to β chains and two insulin receptor monomers are shown as 1956 
grey lines. Abbreviations: M, Myr – myristoylation signal. (B) Autophosphorylation of the 1957 
FV2E-insulin receptor chimera in stably transfected Flp-In T-Rex 293 cells. Expression of the 1958 
chimera was induced for 27 h with 1 μg/ml tetracycline, followed by dimerisation of the 1959 
chimera with 100 nM AP20187 for 1 or 4 h. (C) C2C12 cells were transiently transfected with 1960 
pmaxGFP or pcDNA5/FRT/TO-MyrFV2E-INSR. 24 h after transfection, ER stress was 1961 
induced for 24 h with 0.1 μM thapsigargin, 0.1 μg/ml tunicamycin, or 1 μg/ml SubAB 1962 
followed by dimerisation of the receptor chimera with 100 nM AP20187 for 4 h. ‘#’ indicates 1963 
an unspecific band. Quantification of (D) S473 AKT phosphorylation and (E) the relative 1964 
abundance of α-β proreceptors in panel C. Bars represent standard errors (n = 3-4). p values 1965 
for comparison of the treated to the untreated samples were calculated by ordinary one-way 1966 
ANOVA using Dunnett’s multiple comparisons test. (F) Induction of TRB3 in C2C12 cells by 1967 
ER stress. C2C12 cells were treated with 300 nM thapsigargin, 1 μg/ml tunicamycin, SubAB, 1968 
or SubAA272B for 24 h. TRB3 mRNA levels were determined by reverse transcriptase-qPCR 1969 
and standardised to the loading control ACTB. Bars represent standard errors (n = 3). p values 1970 
for comparison of treated samples to the untreated sample (“-“) were calculated by ordinary 1971 
two-way ANOVA with Dunnett’s multiple comparisons test taking data shown in Figures 1E 1972 
and 1F into account. 1973 
Figure 11. JNKs are not required for insulin resistance in ER-stressed cells. (A) Activation of 1974 
JNK in Hep G2 cells exposed to different concentrations of thapsigargin, but not tunicamycin 1975 
or SubAB, for 18 – 36 h. The arrows indicate the p46 and p54 isoforms of JNKs, the three 1976 
lines phosphorylated species of p38, p42, and p44 MAP kinases. Bars represent standard 1977 
errors (n = 3). p values for comparison of treated samples to the untreated sample (‘-‘) were 1978 
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calculated by ordinary two-way ANOVA with Tukey’s multiple comparisons test. (B) JNKi 1979 
VIII and XVI inhibit phosphorylation of c-Jun at S63 in Hep G2 cells exposed to the 1980 
indicated concentrations of thapsigargin for 36 h. Hep G2 cells were treated with 8 μM JNKi 1981 
VIII or XVI for 0.5 h before exposure to thapsigargin in the presence of 8 μM JNKi VIII or 1982 
XVI or no JNK inhibitor (‘-‘) for 36 h. The bar graphs show S63 phosphorylation of c-Jun 1983 
standardised to c-Jun levels, and c-Jun levels standardised the GAPDH levels. Bars represent 1984 
standard errors (n = 3). p values were calculated by ordinary two-way ANOVA with Tukey’s 1985 
multiple comparisons test on square root or arctangent-transformed data, respectively. (C-E) 1986 
JNKi VIII and XVI do not reverse inhibition of insulin-stimulated phosphorylation of AKT at 1987 
S473 by thapsigargin in Hep G2 cells. Hep G2 cells were treated for 0.5 h with 8 μM JNKi 1988 
VIII or XVI, followed by exposure to the indicated concentrations of thapsigargin in the 1989 
presence of 8 μM JNKi VIII or XVI or no JNK inhibitor (‘-‘) for 36 h. Cells were serum-1990 
starved in the last 18 h of thapsigargin treatment and then stimulated with 10 nM or 100 nM 1991 
insulin for 15 min in the continued presence of thapsigargin and JNK inhibitors, were 1992 
applicable. (C) Western blots for pS473-AKT, AKT, and GAPDH. (D) Quantification of the 1993 
Western blots in panel (C). Bars represent standard errors (n = 3). p values were calculated by 1994 
ordinary two-way ANOVA with Dunnett’s multiple comparisons test. (E) Reanalysis of the 1995 
data in panel D after normalisation of data for each condition of JNK inhibition to the insulin-1996 
stimulated sample not exposed to thapsigargin for the corresponding condition. p values were 1997 
calculated by ordinary two-way ANOVA with Dunnett’s multiple comparisons test. (F) JNKi 1998 
VIII and XVI do not restore levels of insulin receptor β chains or restore processing of α- β 1999 
proreceptors to levels of untreated cells. Hep G2 cells were treated with 8 μM JNKi VIII or 2000 
XVI for 0.5 h before exposure to thapsigargin in the presence of 8 μM JNKi VIII or XVI or 2001 
no JNK inhibitor (‘-‘) for 36 h. Bars represent standard errors (n = 3 for β chains and n = 4 for 2002 
α-β proreceptors). p values were calculated by ordinary two-way ANOVA with Tukey’s 2003 
multiple comparisons test. 2004 
Figure 12. JNK1 and JNK2 are not required for development of insulin resistance in ER-2005 
stressed cells. (A) Serum-starved WT and (B) jnk1-/- jnk2-/- MEFs were treated for 24 h with 2006 
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the indicated concentrations of thapsigargin, tunicamycin, 1 μg/ml SubAB, or 1 μg/ml 2007 
SubAA272B before stimulation with 100 nM insulin for 15 min. (C) Quantification of 2008 
phosphorylation of AKT on S473 relative to total AKT levels in WT and jnk1-/- jnk2-/- MEFs 2009 
exposed to thapsigargin, tunicamycin, and 1 μg/ml SubAB or SubAA272B. Bars represent 2010 
standard errors (n = 12 for unstressed, insulin-stimulated WT MEFs, n = 10 for unstressed, 2011 
insulin-stimulated jnk1-/- jnk2-/- MEFs, n = 6 for all other samples for WT MEFs, and n = 5 for 2012 
all other samples for jnk1-/- jnk2-/- MEFs). p values for comparison of the relative AKT S473 2013 
phosphorylation between WT and jnk1-/- jnk2-/- MEFs were calculated using ordinary two-way 2014 
ANOVA with Šidák’s correction for multiple comparisons. p values for comparison of ER-2015 
stressed samples and samples not stimulated with 100 nM insulin to samples stimulated with 2016 
100 nM insulin were calculated using ordinary two-way ANOVA with Dunnett’s multiple 2017 
comparisons test. (D) Activation of JNK in serum-starved WT MEFs exposed to the indicated 2018 
concentrations of thapsigargin or tunicamycin, 1 μg/ml SubAB, or SubAA272B for 24 h before 2019 
stimulation with 100 nM insulin for 15 min. (E) Quantification of the Western blots in panel 2020 
D. Bars represent standard errors (n = 8 for insulin-stimulated cells, n = 4 for all other 2021 
samples). p values for comparison of ER-stressed samples and samples not stimulated with 2022 
100 nM insulin to samples stimulated with 100 nM insulin were calculated using ordinary 2023 
one-way ANOVA with Dunnett’s multiple comparisons test. (F) JNK deficiency does not 2024 
protect from the effects of ER stress on insulin receptor processing in the secretory pathway. 2025 
The relative abundance of α-β proreceptors was determined by Western blotting of lysates of 2026 
serum-starved WT and jnk1-/- jnk2-/- MEFs exposed for 24 h to the indicated concentrations of 2027 
thapsigargin, tunicamycin, and 1 μg/ml SubAB or SubAA272B followed by stimulation with 2028 
100 nM insulin for 15 min where indicated. Bars represent standard errors (n = 4 for 2029 
unstressed, insulin-stimulated cells, n = 2 for all other samples). p values for comparison of 2030 
the relative abundance of α-β proreceptors between WT and jnk1-/- jnk2-/- MEFs were 2031 
calculated by Welch’s test (Welch, 1947) followed by a Games-Howell post hoc test (Games 2032 
and Howell, 1976). p values for comparisons of treatments were calculated by ordinary two-2033 
way ANOVA with Dunnett’s multiple comparisons test. 2034 
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Figure 13. TRB3 is not required for development of insulin resistance in ER-stressed C2C12 2035 
cells. (A) siRNA-mediated knock-down of TRB3 at the mRNA level 48 h after transfection of 2036 
C2C12 cells with 50 nM of the indicated siRNAs. TRB3 mRNA was determined by reverse 2037 
transcriptase-qPCR and normalised to ACTB. Bars represent the standard error from three 2038 
technical replicates. p values were calculated by ordinary one-way ANOVA with Dunnett’s 2039 
multiple comparisons test. (B) siRNA-mediated knock-down of TRB3 at the protein level 48 2040 
and 72 h after transfection of C2C12 cells with 50 nM of the indicated siRNAs. (C) 24 h after 2041 
transfection with the indicated siRNAs C2C12 cells were exposed to 300 μM thapsigargin, 1 2042 
μg/ml tunicamycin or SubAB for 24 h and serum-starved during the last 18 h of exposure to 2043 
ER stressors before being stimulated with 100 nM insulin for 15 min. Phosphorylation of 2044 
AKT at S473 and insulin receptors were analysed by Western blotting. (D) Quantification of 2045 
the relative phosphorylation of AKT at S473 in the Western blots of panel C. Bars represent 2046 
standard errors (n = 5 for cells transfected with siRNAs against eGFP, n = 3 for all other 2047 
samples). p values were calculated by ordinary two-way ANOVA with Dunnett’s correction 2048 
for multiple comparisons. (E) Quantification of the relative abundance of α-β proreceptors in 2049 
the Western blots of panel C. Bars represent standard errors (n = 6 for cells transfected with 2050 
siRNAs against eGFP, n = 3 for all other samples). p values were calculated by ordinary two-2051 
way ANOVA with Dunnett’s multiple comparisons test to compare of samples to the insulin-2052 
stimulated, unstressed sample and Tukey’s multiple comparisons test to compare different 2053 
siRNAs. 2054 
Figure 14. ER stress decreases insulin sensitivity by decreasing the plasma membrane 2055 
population of the insulin receptor. (A) Inhibition of insulin signalling by ER stress requires 2056 
transport of newly synthesised insulin receptors from the ER to the cell surface. The signal 2057 
peptide sequence targets ribosomes translating the insulin receptor mRNA to the ER, where 2058 
the newly synthesised polypeptide chain folds into molecules with insulin binding activity. 2059 
ER stress interferes with folding of newly synthesised insulin receptor molecules, preventing 2060 
its transport to the Golgi complex. The Myr-FV2E-insulin receptor chimera is not affected by 2061 
ER stress because it is translated by cytoplasmic ribosomes and folds in the cytosol into active 2062 
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molecules thus bypassing the ER. Abbreviation: TGN – trans-Golgi network. (B and C) 2063 
Modelling of the response to insulin as a function of insulin and insulin receptor 2064 
concentration. The response to insulin, R, is defined by the equation R = Rmax·[INS·INSR]/(KE 2065 
+ [INS·INSR]), with KE – concentration of insulin (INS)-insulin receptor (INSR) complexes 2066 
at which R = 0.5·Rmax, and Rmax – maximal response to insulin. The concentration of insulin-2067 
insulin receptor complexes is calculated from the equilibrium INS + INSR ↔ INS·INSR 2068 
considering only high affinity binding of insulin to the insulin receptor with a dissociation 2069 
constant of 200 pM (Bass et al., 1996). KE varies widely for different physiological responses 2070 
to insulin (Gammeltoft and Gliemann, 1973; Hofmann et al., 1980; Crettaz and Kahn, 1984) 2071 
and has been assumed to be equal to 1 pM for illustrative purposes only. Numbers represent 2072 
the half-lives of the insulin receptor at the cell surface that have elapsed since ER stress was 2073 
induced. 2074 














